Hauer on ABC News, the afternoon/evening of September 11, 2001
born oct 31, 1951 : https://www.ancestry.com/discoveryui-content/view/243099965:1732?tid=&pid=&queryId=d3cabb6908ad942708c5ae6c630aeb2e&_phsrc=llt222&_phstart=successSource
Jerome Maurice Hauer
Marriage Date: 25 Oct 2003
Marriage Place: Prince William, Virginia, USA
Name : Jerome Maurice Hauer
Birth Year : 1951
Source: Who's Who in Frontier Science and Technology. First edition, 1984- 1985. Chicago: Marquis Who's Who, 1984. (WhoFrS) Who's Who in the World. Seventh edition, 1984-1985. Wilmette, IL: Marquis Who's Who, 1984. (WhoWor 7)
Steven Jay Hatfill (born 1953) ( ... )
...
Jerome M. Hauer - Director, NYC Office of Emergency Management
In office : February, 1996 – February, 2000
Appointed by : Rudolph Giuliani
Succeeded by : Richard J. Sheirer
Jerome M. Hauer Commissioner, NYS Division of Homeland Security and Emergency Services
In office : October, 2011 – December 2014
Appointed by : Andrew M. Cuomo
Succeeded by : John Melville[1]
Jerome M. Hauer is the chief executive officer of a consulting firm, The Hauer Group LLC. He has also held several governmental positions related to emergency management in the states of New York and Indiana. He has also worked as a member of the Hollis-Eden Pharmaceuticals board of directors.
Hauer served as Commissioner of Homeland Security and Emergency Services for the government of New York State from October, 2011 until December 2014.[2][3]
Commissioner Hauer with NYS Gov. Andrew M. Cuomo and MTA Chairman Joseph J. Lhota discussing the response to Hurricane Sandy
Hauer was the acting assistant secretary for the Office of Public Health Emergency Preparedness (OPHP) within the US Department of Health and Human Services (DHHS). He was appointed by HHS Secretary Tommy G. Thompson on May 5, 2002 and served until replaced on April 28, 2004. In this role, Hauer was responsible for coordinating the country’s medical and public health preparedness and response to emergencies, including acts of biological, chemical and nuclear terrorism.
He was formerly the director of New York City's Office of Emergency Management under mayor Rudy Giuliani from 1996 to 2000. Additionally, he was previously an employee of Kroll Inc. which studied biological terrorism attacks.
Hauer was the director of the Indiana Department of Emergency Management from 1989 to 1993 during the gubernatorial administration of Evan Bayh. Hauer joined IBM in 1993 to manage programs for Hazardous Materials Response and Crisis Management and Fire Safety. For his production of related training videos he received the International Film and TV Critics of New York Bronze award in 1996. In the early 1990s he received a master's degree in emergency medical services from the Johns Hopkins University School of Hygiene and Public Health (now known as the Johns Hopkins School of Public Health) and later became a member of the Johns Hopkins Working Group on Civilian Bio Defense. He wrote several articles on possible bio terrorist attacks. On April 10, 1998 Hauer attended a "roundtable on genetic engineering and biological weapons" under President Bill Clinton. Hauer holds a Ph.D. from the Defence Academy of the United Kingdom, Cranfield University.[citation needed]
Hauer was known for his pioneering work on autotransfusion in cardiac surgery and trauma. In 1978 Hauer developed the first unit to reinfuse blood lost following cardiac surgery, reducing the risk of hepatitis. That work reduced before morbitiy and mortality in these patients. He was issued a patent for his device. Before he became a Giuliani commissioner he had previously run emergency management programs for the State of Indiana and IBM.
On September 11, 2001, Jerome Hauer was a national security advisor with the Department of Health and Human Services, a managing director with Kroll Associates, and a guest on national television, because of his background in counter-terror and his specialized knowledge of biological warfare.[citation needed]
Jerome M. Hauer was the first director of Mayor Giuliani's Office of Emergency Management. He directed the agency since 1996, when Giuliani shifted responsibility for the city's emergency preparedness from the police department to the new agency – headed by Hauer.
Giuliani and Hauer began their relationship in January 1996 when Hauer was hired to lead the new Office of Emergency Management, created to coordinate the city’s response to crises.
Jerome Hauer is best known for being the director of the New York City Office of Emergency Management (NYC OEM) when he made the decision to build a $13 million crisis center on the 23rd floor at 7 World Trade Center.[4] This crisis center was unveiled in June 1999, and became the subject of tension between the agency and the police department, whose own command center at 1 Police Plaza had until then been the focus of emergency preparedness operations.
As the first director of the new crisis center, "one of Hauer’s first tasks was to find a home for an emergency command center to replace the inadequate facilities at police headquarters," according to the Times. The site selected, was immediately controversial because it was part of the World Trade Center complex (although not in one of the Twin Towers), which had already been the location of a truck bomb attack in 1993. City officials, though, including Hauer, have long defended their decision, even after the command center had to be evacuated during the 2001 terror attack. The Emergency Operation Center was widely hailed as the finest such facility in the nation, receiving visitors from around the world and serving as a model for others. A memo revealed by Chris Wallace on Fox news showed that Hauer wanted to put the command center in Brooklyn but was forced by Guilliani to put the facility within walking distance of City Hall.
The center was destroyed when the 47-story tower collapsed at about 5:25 p.m. on 9-11.
http://www.upmc-biosecurity.org/website/events/2000_symposium-2/hauer/
2000-upmc-biosecurity-org-events-2000-symposium-2-hauer.pdf
Jerome Hauer, MPH
Managing Director, Kroll Worldwide, Crisis and Consequence Management
Olympics 2000: Preparing to Respond to Bioterrorism
Published proceedings Raw transcript Next speaker
Professional Biography
Jerome M. Hauer, one of the nation's leading experts on biological and chemical terrorism, recently left his post as Director of New York City's Office of Emergency Management (OEM) to join Science Applications International Corporation (SAIC). Hauer, who served four years as the City's first OEM Director, will be SAIC's Assistant Vice President and Associate Director of Center for Counterterrorism Technology and Analysis.
During his tenure at OEM, Hauer was charged by the Mayor with coordinating the City's on-scene response to multi-agency emergencies. He was also given the responsibility of drafting the City's emergency response plans to natural and man-made events, including hurricanes and coastal flooding as well as biological or chemical attacks.
Hauer has a Masters degree from the Johns Hopkins School of Public Health and over 20 years of experience in emergency management. He was recently selected to be one of six scientists to brief President Clinton on biological terrorism and has been asked by the World Health Organization to co-author a rewrite of its 1970 monograph on chemical and biological weapons. Hauer consults regularly with Scotland Yard and the Israeli military and works extensively with the Australian Government in its preparations for the 2000 Summer Olympics.
Hauer has served on the National Academy of Sciences Institute of Medicine's Committee to Evaluate R&D Needs for Improved Civilian Medical Response to Chemical or Biological Terrorism Incidents, and is an advisor to the United States Capitol Police and the United States Marine Corps' Chemical-Biological Incident Response Force (C-BIRF). Hauer is also a member of the Johns Hopkins Working Group on Civilian Bio Defense and is an advisor to the Department of Justice's Office of Justice Programs.
Prior to assuming his position at OEM, Hauer served as the Executive Director of the State of Indiana's Emergency Management Agency as well as its Department of Fire and Building Services. During that time he participated on the Congressional Fire Caucus' Urban Search and Rescue Advisory Committee as well as the National Institute for Urban Search and Rescue Advisory Council. Hauer was named Chairman of the Board of Directors of the U.S. Earthquake Consortium in 1990 and then again in 1991. He also served as co-chairman of the State of Indiana's Emergency Response Commission and as Chairman of the Board of Directors of the State's Public Safety Training Institute.
In 1987, Hauer was named Deputy Director for Emergency Management for the City of New York's Emergency Medical Services. Four years earlier, Hauer joined the Biomedical Division of IBM as Clinical Research Coordinator, later taking responsibility for the company's Hazardous Material Response Programs, Crisis Management, Fire Safety and Emergency Medical Response at the Corporate level. While there, he developed policy for ensuring the safety of IBM personnel when responding to emergencies or incidents involving hazardous material. A series of hazardous materials training videos produced by Hauer earned him the International Film and TV Critics of New York Bronze Award in 1986.
During this time, Hauer also served as a volunteer firefighter in Ridgefield, Connecticut, and was a member of the Fairfield County Hazardous Materials Response Team. He was a captain in the U.S. Army Reserve attached to the Walter Reed Army Institute of Research in Washington, DC, a component of the Medical Research and Development Command, where he worked on resuscitation techniques for combat casualty care.
Hauer has also served on the U.S. Geologic Survey's ad hoc working group on earthquake-related casualties as well as the National Fire Protection Association?s Technical Committee on Disaster Management.
While at Hopkins, Hauer developed the first technique for reinfusing blood lost by patients following cardiac surgery. Following graduation from Johns Hopkins, Hauer spent a short time at the Maryland Shock Trauma Unit and then joined the Beth Israel Hospital in Boston as Research Associate. Most of his work focused on autotransfusion and coagulopathies in trauma and cardiac surgery. Additionally, Hauer served on the faculty of the Northeastern University Paramedic Program and was a teaching assistant in the physiology labs for first- and fourth-year students at Harvard Medical School. He co-directed the first two postgraduate courses in Trauma Management at the Longwood Area Trauma Center of the Harvard Medical School.
Hauer is the recipient of numerous honors including the Outstanding Alumni of the Year from the Johns Hopkins School of Hygiene and Public Health, the Indiana Commendation Medal for Exceptional Meritorious Service, Legion of Hoosier Heroes Award and the Distinguished Alumni Award from NYU. He is a member of the New York City Police Department?s Honor Legion, and is an honorary Assistant Chief in the New York City Fire Department.
Hauer has contributed to 34 publications, a book and two monographs.
https://www.newspapers.com/image/491515066/?terms=lederberg%20hauer&match=1
1996-07-01-the-daily-news-pg-17-clip-hauer-lederberg
https://www.newspapers.com/image/565539155/?terms=lederberg%20hauer&match=1
1998-04-10-lancaster-new-era-pennsylvania-pg-5.jpg
1998-04-10-lancaster-new-era-pennsylvania-pg-5-clip-white-house-w-lederberg.jpg
By William J. Broad and Judith Miller / Aug. 7, 1998 / PDF of article : [HN0206][GDrive]
Mentioned : Dr. Jerome Maurice Hauer (born 1951) / Dr. Thomas Patrick Monath (born 1940) / DynPort Vaccine Company, LLC / Dr. Barbara Hatch Rosenberg (born 1930) / Dr. Joshua Lederberg (born 1925) / Dr. John Craig Venter (born 1946) / Dr. William Capers Patrick III (born 1926) /
On May 22, President Clinton unveiled an ambitious plan to stockpile vaccines at strategic sites around the country so communities could better fight germ attacks. ''We must do more to protect our civilian population,'' Mr. Clinton told graduating midshipmen at the United States Naval Academy in Annapolis, Md. ''We must do more to protect our people.''
While such major initiatives usually result from many months and sometimes years of fierce debate, this one, Federal and private experts said in interviews, was developed in record time, rushed through amid worries of rising threats from Iraq and germ terrorists. But today the multimillion-dollar plan is in jeopardy, a victim in part of the haste in which the decision was reached.
Some Government officials are calling for a different approach that initially plays down vaccines in favor of antibiotics. Others defend vaccines, but concede that getting them quickly is nearly impossible, given industry's production limits and the need to insure vaccine safety and effectiveness. Still others fault vaccines as offering little or no protection against such deadly threats as smallpox and anthrax, seen as likely weapons in germ attacks.
A review of events leading to the Clinton vaccine decision reveals that the proposal was pushed by a small group of scientists, businessmen and policy makers who largely shared the same views as they struggled to do something, anything about a threat whose dimensions were potentially terrifying but frustratingly unclear. Working in Washington's frenetic, often insular world, they tended to overwhelm or sidestep doubters, and failed to see warning signs.
*The apparent consensus on acquiring vaccines masked deep divisions among scientists and military officials.
[Dr. William Capers Patrick III (born 1926)], who made germ weapons for the United States before President Richard M. Nixon outlawed them nearly three decades ago, warned that vaccinations against particular germs could be easily countered by foes, making such safeguards potentially useless.
''It's a hell of a problem,'' Mr. Patrick said. ''Defensive measures are much more difficult than offensive ones. There's no easy way around it. You immunize against anthrax and then an enemy just tries something else.''
Even the Administration's top public health officials have begun to warn that stockpiling is no quick fix.
''My view is that the stockpile isn't sufficient,'' said a senior Administration official, who spoke on condition of anonymity. ''We need an entire care system in place'' to avoid creating a false sense of security.
And Congress, which has strongly supported the Administration's anti-terrorism efforts, is questioning the rationale and structure of the civilian stockpile. A Senate hearing is being considered for the fall.
''The plan,'' said Senator Lauch Faircloth, Republican of North Carolina, ''needs to be more carefully thought out and discussed more publicly.''
For decades, scientists and military officials debated the merits of vaccines as a defense against germ warfare. Worries grew after the 1991 Persian Gulf war, when United Nations inspectors found that President Saddam Hussein of Iraq had studied dozens of microbial agents and had placed at least 180 biological bombs and warheads around his country ready to spray lethal germs on enemy troops.
As the Pentagon discussed an ambitious program to make a variety of vaccines, its officials weighed the possibility that enemies would simply choose new deadly germs or modify old ones to outwit American defenses.
''People asked if we were just making it possible for Saddam to pick another agent,'' recalled Stephen C. Joseph, a doctor who at the time was Assistant Secretary of Defense for health affairs.
Dr. Joseph added that he and his Pentagon colleagues nonetheless recommended in the mid-1990's that the military embark on a vaccine effort. They were motivated in part, Pentagon officials said, by intelligence reports of rising dangers outside Iraq of germs being used against American troops.
In 1996, the Pentagon began looking for a company to develop and obtain licenses for 18 vaccines other than the standard one for anthrax. The initial ones were to guard against smallpox, which causes fever, boils and can be fatal; tularemia, which causes chills, aches, fatigue and typhoid-like symptoms, and Q-fever, which causes headaches, weakness and coughing.
In November 1997, the Pentagon awarded a $322 million, 10-year contract for the 18 vaccines to [DynPort Vaccine Company, LLC], a British-American venture. The plan sidestepped the knotty issue of immunizing troops, focusing instead on making and stockpiling vaccines for military personnel.
Exactly how the Pentagon would use its stored vaccines would depend on future events and threats.
Late last year, worry in the Pentagon about biological attacks turned to alarm as United States troops prepared to strike Iraq after President Hussein expelled Americans from international teams investigating his germ arsenal. On Dec. 15, Defense Secretary William S. Cohen announced that all 2.4 million American troops would get anthrax shots. Pentagon officials said the effort would take six years and cost $130 million.
Just at that moment, the theory of enemy countermeasures became real publicly for the first time. In December, Russian scientists stunned the biological world by disclosing that they had used genetic engineering to make a new anthrax microbe. It attacked blood cells and made Russia's vaccine useless.
Whether the organism was a laboratory curiosity or a battlefield weapon was unclear. The Russian scientists gave out no samples, so detailed analysis was impossible. But Western military officials were shaken and wondered whether the American anthrax vaccine was now obsolete, and whether the same was true of other vaccines in development.
''It's not just an academic debate anymore,'' said Jack Melling, director of the Salk Institute in Swiftwater, Pa., a vaccine center that does research for the Defense Department.
The news got worse in February. Ken Alibek, a top Russian defector, went public to assert that Moscow was working on a range of exotic germ weapons, including hybrids of the smallpox virus that cause profuse bleeding. If real, such germs could sow plagues that kill most victims.
Around that time, President Clinton became fixated on the emerging germ threat and ways to counter it among civilians, aides said.
Influences are said to have included the Iraqi crisis, the Russian claims, the intelligence reports and a novel, ''The Cobra Event'' (Random House, 1997), about a terrorist attack on New York City with a genetically engineered mix of the smallpox and cold viruses. Mr. Clinton was so alarmed by the book, his aides said, that he instructed his intelligence experts to assess its credibility and urged Speaker Newt Gingrich, Republican of Georgia, to read it.
Aides said the President and his National Security Council increasingly wrestled with the danger of biological attacks not only on troops abroad but also on American cities, states or even the entire country.
In January, in his State of the Union address, Mr. Clinton vowed to confront the hazard of germ weapons obtained ''by outlaw states, terrorists and organized criminals.''
In March, the White House held a secret exercise to play out what would happen if terrorists struck with one of the theoretical smallpox hybrids. The results of the war game were grim and fueled a Federal drive to find better ways to cope with such an attack.
In April, the President explored ways in which modern biology might help. He and his top officials met at the White House on April 10 with seven private scientists in the Truman Room, where Cabinet meetings are held. For an hour, participants say, the scientists discussed the germ topic and pushed for a vaccine stockpile.
Mr. Clinton's attending officials included the Secretary of Defense, the Attorney General, the Secretary of Health and Human Services, the Director of Central Intelligence and the national security adviser.
The scientists present were Dr. Frank E. Young, a former head of the Food and Drug Administration, who moderated the panel; [Dr. Joshua Lederberg (born 1925)], president emeritus of Rockefeller University; Dr. Lucille Shapiro, a biologist at Stanford University; [Dr. Jerome Maurice Hauer (born 1951)], head of emergency management for New York City; and [Dr. Barbara Hatch Rosenberg (born 1930)], a biological arms-control expert at the Federation of American Scientists, a private group.
The scientific panel also had two industry experts, both with financial ties to vaccine work.
One was a pioneer of genetic engineering who had decoded the smallpox virus and other microbes and used the meeting to push his own scientific agenda, participants said. But that researcher, [Dr. John Craig Venter (born 1946)], president of The Institute for Genomic Research, a nonprofit biotechnology group just outside Washington, said he simply urged the Government to step up support for the genetic mapping of deadly microbes. The insights, Dr. Venter added, would aid vaccine development and new methods of germ detection and treatment.
''The argument is that if we decipher these genomes it could be the ultimate deterrent,'' Dr. Venter said, referring to the ability to have so many avenues of defense that germ attacks would become futile.
Over the years, his institute had received millions of dollars in Federal support and is now gearing up to use more Government money to map the anthrax microbe as an aid to germ defense.
At the White House meeting, participants said, the business interests of another scientist were less well known.
[Dr. Thomas Patrick Monath (born 1940)] was identified in a White House announcement as a vice president of Oravax and a former official of the Centers for Disease Control and the United States Army Medical Research Institute of Infectious Diseases, the Government's top body for defensive germ-warfare studies.
A graduate of Harvard College and the Harvard Medical School, a world authority on yellow fever and other epidemics, Dr. Monath had devoted most of his career to public service.
At the meeting, he was viewed mainly through that lens, participants said, who added that they knew little about his company other than it worked on vaccines.
Based in Cambridge, Mass., Oravax was founded in 1990 to tap an emerging multibillion-dollar market in oral vaccines and antibodies to combat infectious diseases. But the small company kept having problems getting beyond research and bringing products to market.
By 1996 and 1997, its survival at stake, Oravax tried to win part of the Pentagon's expanding germ work as a subcontractor to make smallpox vaccines and others. By early this year, that work had failed to materialize and the company's stock price was down 90 percent from $10 a share in the initial public offering.
Memories of meeting participants varied, but no one could recall [Dr. Thomas Patrick Monath (born 1940)] telling the President of his company's financial interest in vaccine stockpiles -- a step he now insists that he took.
''The way to handle it is to be open, so people understand that I may have a potential bias,'' Dr. Monath said. ''I don't make it a business of taking advantage of situations in which I'm asked to participate to push the Oravax agenda.''
Many participants remember [Dr. Thomas Patrick Monath (born 1940)] arguing forcefully for stockpiling, a subject he had been asked by the panel's moderator to discuss.
[Dr. John Craig Venter (born 1946)] said the views of Dr. Monath, while strong, reflected the panel's consensus.
''Even through he was pushing harder than anyone else,'' Dr. Venter said, ''our recommendations to develop stockpiles of vaccines and medicines would have come out the same.''
A retired Army colonel, [Dr. Thomas Patrick Monath (born 1940)] was most likely the only scientist in the room who had deeply studied such problems for germ defense as enemy countermeasures.
That topic, participants say, was discussed little and in any case was overshadowed by [Dr. John Craig Venter (born 1946)]'s repeated assertions that genetic advances in theory had the power to solve these problems.
The Presidential briefing was such a hit that the experts were asked to take it on the road. In the following weeks, the scientists delivered their views to senior officials involved in vaccine issues at the Pentagon and the Department of Health and Human Services, participants said.
On May 6, the panel delivered a follow-up report to the President that, among other things, called for a stockpile of drugs and vaccines to protect millions of Americans against a variety of germs, up to 40 million against smallpox. The total cost over five years was estimated at $420 million.
Such a stockpile, the report said, could help ''reduce the death and illness 10 to 100 fold.''
A White House official who spoke on the condition of anonymity said the recommendation by the scientific panel simply encouraged the Administration to do what it was already contemplating. The official added that he saw no conflict of interest in [Dr. Thomas Patrick Monath (born 1940)]'s participation because his company had signed no Federal contracts for vaccine production.
Government ethics experts say that such private White House advisers are exempt from Federal conflict-of-interest rules and that Dr. Monath, even if he had an undisclosed interest, broke no law.
The White House official called Dr. Monath ''very knowledgeable,'' adding, ''The point of the meeting was to get a wide range of opinions from leading experts.''
The Pharmaceutical Research and Manufacturers of America, a Washington trade group that represents the nation's top 100 drug companies (Oravax is not among them), said it was never contacted by the White House for advice on the stockpile idea.
Oravax at this time was increasingly desperate. In filings to the Securities and Exchange Commission, the company said it had won part of the Pentagon vaccine work.
Its stock price continued to slide. On May 4, the company put out a news release boasting of the contract, and the stock rose that day in heavy trading to $1.31, up from $1.00.
But in fact, Oravax had only a preliminary promise of possible work as a subcontractor to the British-American venture that had won the Pentagon contract, executives from both companies now agree.
Securities lawyers say such misrepresentations in S.E.C. filings are potential violations of Federal securities laws.
Later that month, as rumors and news reports suggested that the President was about to announce a civilian stockpiling effort, Lance K. Gordon, Oravax's president, issued a press release saying the company was prepared to take on the challenge.
''Although there is no guarantee that Oravax will be involved,'' Mr. Gordon said in the May 21 statement, ''the company believes it has the capacity to produce both smallpox and tularemia vaccines for civilian use.''
The next day, a Friday, Mr. Clinton announced the new push to create stockpiles of ''medicines and vaccines to protect our civilian population.'' He also praised gene research as ''very, very important'' to developing new ways of countering germ terror.
The same day, 2,413,100 shares of Oravax changed hands in the Nasdaq market, closing at $1.41, up 28 cents, or 25 percent. It was the stock's heaviest trading day ever. Later, the company issued a statement explaining the sudden activity, which it attributed to the President's action.
For [Dr. Thomas Patrick Monath (born 1940)], who owns or has options on 150,574 shares, the stock's price increase amounted to a profit on paper of $42,160.
A quiet war erupted as Federal agencies and experts weighed in heavily for the first time. The Department of Health and Human Services, designated to oversee the stockpile, was ambivalent about the project, officials said. The agency faulted the initiative as simplistic, saying the plan put too little emphasis on the costly, painstaking work of improving the nation's public health network to cope with germ attacks.
Significantly, the agency found that no company was making, or would soon be able to make for civilians, the vaccines scheduled to be stockpiled. It therefore switched the emphasis to antibiotics. Though also potentially vulnerable to enemy countermeasures, these drugs were seen as having the benefit of fighting a variety of noxious germs.
Two weeks after the President's announcement, on June 8, the Government quietly began to back pedal. Even though the White House asked Congress for $51 million in the next fiscal year to develop ''a civilian stockpile of antidotes, antibiotics and vaccines,'' that same day Administration officials disclosed that vaccines had been ruled out for the moment. Why? Cheaper and more effective ones might appear in the next few years, the officials told reporters.
The developing plan has yet to address in detail how and where the medicines would be made, stored or distributed in a crisis.
As for Oravax, its stock is down, closing yesterday at 56 cents. And it still has no Federal stockpile work.
Despite the setbacks, many experts continue to back vaccines as important for germ defense and even hold out the possibility of wide civilian immunizations.
''Preventing an outbreak is always preferable to trying to suppress one after it has started,'' Senator Faircloth said.
As for the worry that an enemy might outwit vaccines with new or modified germs, vaccine supporters say that most of these enhanced germs are theoretical and would probably be less available and attractive to terrorists than known strains of deadly, dependable germs like unmodified anthrax and smallpox. If so, they say, vaccines are a good deterrent and a relatively cheap insurance policy.
Whatever their flaws or merits, vaccines continue to draw the interest of small companies eager to gain a foothold in an expanding area of the Federal budget.
On July 7, the State of Michigan approved the sale of the nation's only licensed maker of anthrax vaccine to a company led by Adm. William J. Crowe Jr., a former Chairman of the Joint Chiefs of Staff who was an important supporter of Mr. Clinton in the 1992 Presidential campaign.
Admiral Crowe's newly formed company has individuals with extensive drug industry experience and now has an inside track on at least $60 million in Pentagon contracts, officials of the Defense Department said. And while aiming at the military market, it wants to expand to civilian customers as well, company officials said, if that becomes possible in the years ahead. Companies drawn to the germ-defense business see the emerging civilian market as potentialy dozens of times larger than the military one and much more profitable.
Vaccines are made of dead or weakened germs. When they are injected -- or, in some cases, swallowed -- vaccines alert the body's immune system, which forms antibodies to fight a particular disease.
In contrast, antibiotics attack invading germs rather than work pre-emptively. Their chemical assaults weaken the invaders to help the immune system fight the infection. Typically, success requires daily doses. Antibiotics can work against a variety of microbes, making them more flexible than vaccines. But they cannot kill viruses, a crucial shortcoming.
To counter germ attacks, both vaccines and antibiotics can be administered in advance. But that step, while potentially effective, is laden with logistic, legal, cost and medical problems, especially with vaccines that in their current state of development carry some risk of causing accidental illnesses.
In theory, stockpiles of vaccines and antibiotics are useful for biological defense because the medicine can be administered quickly to help stop epidemics in progress, just as quick immunizations can help control natural outbreaks.
With vaccines, the Clinton Administration is pursuing a variety of options. It is vaccinating troops against anthrax, preparing to stockpile other vaccines for the military and embarking on a parallel stockpiling effort for civilians. For now, that step is caught up in debate and delay.
1999 (JULY 27) - https://www.nytimes.com/1999/07/27/nyregion/what-could-go-wrong-it-s-his-job-to-know.html?searchResultPosition=7
1999 (oct 16) - https://www.nytimes.com/1999/10/16/nyregion/new-york-city-seeks-us-aid-on-cost-of-virus.html?searchResultPosition=8
2000 (FEB 02) - https://www.nytimes.com/2000/02/02/nyregion/director-of-emergency-agency-is-leaving-for-a-corporate-job.html?searchResultPosition=6
2001-05-08-cpan-usa-federal-efforts-combating-terrorism-day-1-lowrez-recaptured-at-1080p-compressed
2001-05-08-cpan-usa-federal-efforts-combating-terrorism-day-1-lowrez-recaptured-at-1080p-compressed
https://www.newspapers.com/image/377991753/?terms=%22jerome%20hauer%22&match=1 - Dark Winter .. with Nunn - and DTRA leaders..
2001-08-17-the-baltimore-sun-pg-2a.jpg
2001-08-17-the-baltimore-sun-pg-2a-clip-exercise-exposes-weakness
Posted by 911InvestigationVids on Jul 25, 2011
Downloaded copy of this video : [HV00I3][GDrive] / Still image of youtube download page : [HV00I4][GDrive]
"Then it collapses two hours after this inteview, what a miracle! ABC 3:00 pm September 11 2001. Jerry Hauer never had to answer for incredible incompetence or obvious prior knowledge. A highly engineered steel structure cannot fall perfectly into its footprint at the rate of gravitational acceleration from small poorly combusted isolated fires. They abandoned the OEM BEFORE the towers collapsed on the OEM building, which later fell in a perfect controlled demolition"
Youtube link below: (or go to https://www.youtube.com/watch?v=SL7oNrieAqw )
longer verison - https://www.youtube.com/watch?v=Dj0Rz9ZsDAg
2008-04-15-youtube-11septembervideos-jerome-hauer-abc-9-11-14-53-320p-x-240p
2008-04-15-youtube-11septembervideos-jerome-hauer-abc-9-11-14-53-hits-1080p-cover.jpg
https://www.youtube.com/watch?v=sbJTYUhtsaM
Jan 16, 2014
2014-01-16-youtube-911investigationvids-911-oem-director-jerome-hauer-false-caollapse-threats-evidence-removal-ops-480p-x-360p.mp4
https://drive.google.com/file/d/1LVp0CURwGlUO3m2vETOxrD0MUC3TwM4g/view?usp=sharing
2014-01-16-youtube-911investigationvids-911-oem-director-jerome-hauer-false-caollapse-threats-evidence-removal-ops-img-1.jpg
https://drive.google.com/file/d/1Zr5lGOeLQkKo4m8nEmYR4PKQLRpnPaDs/view?usp=sharing
2014-01-16-youtube-911investigationvids-911-oem-director-jerome-hauer-false-caollapse-threats-evidence-removal-ops-img-hauer-profile.jpg (top)
September 12, 2001. One Liberty Plaza was not about to collapse, a false story used to keep the site clear while hurriedly removing the evidence the day after 9/11. Mr. WTC 7, Jerry Hauer lying about collapses, surprised?
No other large police force in the country had developed such sophisticated antiterrorism strategies. None had done as much training or had received as much expert counsel on how to prepare for a terrorist catastrophe.
In fact, the New York Police Department had spent heavily on equipment, participated in mock disasters to test its readiness, maintained a high-tech command center, and advised on the construction of the mayor's own $7 million emergency bunker in a downtown high rise.
But when two planes hijacked by terrorists crashed into the two towers of the World Trade Center last Tuesday, causing the buildings to collapse, the department's ability to carry out its emergency-management plans was seriously compromised.
The bunker, at 7 World Trade Center, was damaged and soon fell along with the rest of the building. The department's communications system was damaged as well, and the ability of senior officials to stay in touch was curtailed for much of the first day. To make matters worse, at least two dozen officers, including some of the men who had been trained most extensively in search and rescue operations, were lost in the tragedy's first hour.
But in what police officials regard as a striking achievement in improvisation and commitment, the department, often using tools no more complex than pens and paper, has managed to recover quickly and respond, not only to the trade center crisis, but also to the demands of effectively policing the rest of the city.
''It's really a test for the entire department,'' Police Commissioner Bernard Kerik said on Friday. ''It's a test for the managers, it's a test for the administrators and it's a test for the rank-and-file cops and the first-line supervisors. And everybody is acting; they are far surpassing what I would have imagined under the circumstances.''
And circumstances were initially close to overwhelming. After the towers collapsed, every phone went dead at police headquarters downtown, the home of its own command center. Pager and cellular phone service was completely lost for nearly 24 hours. E-mail and other computer communications were also knocked out.
The loss of cellular phones and pagers increased the already heavy flow of radio transmissions as department officials scrambled to deploy more officers. ''We made the best with what we had and we made it work,'' Mr. Kerik said.
Jerome M. Hauer, who until last year ran the city's Office of Emergency Management, said the improvisation was rooted in readiness. ''Our Police Department has been and is better prepared for any type of incident than any department in the country, hands down,'' he said.
Within a few hours of the collapse, the department was calling in all off-duty officers to work, and by day's end, it had switched from 8-hour to 12-hour shifts.
Tuesday afternoon the department, along with the Mayor's Office of Emergency Management, opened a makeshift command center at the police academy, and department technicians began running phone lines into a few essential offices inside headquarters.
As more than 1,000 officers responded to the stricken area south of 14th Street, Mr. Kerik redeployed some 10,000 others -- narcotics and precinct detectives and officers from the Organized Crime Control Bureau, the Street Crime Unit and other special units -- to patrol duties.
With the additional help, Mr. Kerik said, the department has had no problem patrolling the streets. Citywide, he said, crime was down by 30 percent during the first days of the crisis.
He also said that the extraordinary public support the officers had seen had energized the police at the moment when they needed it most.
''Now the entire city is out there cheering and clapping and sending letters and just really showing their signs of support for the cops,'' Mr. Kerik said.
''You know what that's doing for them? It's just boosting and enhancing the morale, it's making it, as bad as it is, as tragic as it is, so much better.''
By William J. Broad and Melody Petersen / Sept. 23, 2001 / Source : [HN01OP][GDrive]
(also printed at 2001 (Sep 23) https://www.newspapers.com/image/118390275/?terms=%22jerome%20hauer%22&match=1 )
Minutes after two jets slammed into the World Trade Center, an elite team of 22 soldiers was ordered from its base in Scotia, N.Y., to the scene of the disaster, the world's worst terror attack.
By 8:30 that night, the unit had deployed special gear in New York City and was quietly sampling the air, making sure the terrorists had released no deadly germs or toxic chemicals, which in theory could cause widespread illness and death.
No such dangers were found. But despite the fast start, experts say civil defenses across the nation are a rudimentary patchwork that could prove inadequate for what might lie ahead, especially lethal germs, which are considered some of the most dangerous weapons of mass destruction. Many experts approve of President Bush's decision to appoint a cabinet secretary for Homeland Security, calling it an important step toward protecting civilians against terrorist arms.
The emergency teams ''did very well in dealing with this attack,''[Dr. Tara Jeanne O'Toole (born 1951)], a physician at the Center for Civilian Biodefense Studies at Johns Hopkins University, said in an interview. ''But we've never really had a test of the hospital system where people in large numbers required sophisticated medical care.''
Moreover, there are no measures to routinely check for biological attack. Instead, the authorities rely on reports from doctors that people are seeking medical attention for unusual symptoms. That is why the Centers for Disease Control and Prevention in Atlanta issued a national alert on Sept. 11 calling on public health officials to ''initiate heightened surveillance for any unusual disease occurrence or increased numbers of illnesses that might be associated with today's events.''
The alert is still in effect. ''We haven't heard a thing,'' one federal official, who spoke on condition of anonymity, said of any reports of unusual disease patterns.
But medical experts often fault this approach as inadequate, especially because symptoms of serious illness often appear days and weeks after an infection has begun to spread and when life-saving treatments are no longer effective.
The nation is ''woefully unprepared to deal with bioterrorism,'' Jerome M. Hauer, former head of emergency management for New York City, told Congress two months ago.
How serious is the threat? Today it is considered low. Experts say that biological weapons, with few exceptions, are hard to make and use. In the early 1990's, Aum Shinriko, a Japanese cult, launched germ attacks in and around Tokyo that were meant to kill millions. The strikes produced no known injuries or deaths.
But the chances that some rogue state or terrorist group will successfully deploy germ weapons are seen as rising, as knowledge of how to make deadly weapons spreads, along with the necessary technology.
''There's a greater risk of dying on the highway than from exposure to anthrax,'' said Jonathan B. Tucker, a germ-weapons expert in the Washington, D.C., office of the Monterey Institute of International Studies.
But Dr. Tucker cautioned that the attacks on New York and near Washington were unusual in showing a high degree of care and preparation, suggesting that terrorists ''may be able to overcome the technical hurdles'' to mass destruction, especially if aided by rogue states or scientists.
George J. Tenet, director of central intelligence, warned Congress last year that terrorists were exploring how ''rapidly evolving and spreading technologies might enhance the lethality of their operations.'' A number of groups, he said, are seeking germ, chemical, radiological or nuclear arms.
Mr. Tenet added that operatives of Osama bin Laden, the renegade Saudi millionaire suspected in the Sept. 11 attacks, ''have trained to conduct attacks with toxic chemicals or biological toxins.''
Military experts say germ weapons can be cheaper, stealthier and potentially more devastating than nuclear arms, though hard for terrorists to acquire and use without hurting themselves.
Shock waves from the recent suicide attacks, experts agree, could help forge a consensus to erect better defenses against unconventional weapons, reversing decades of neglect of civil defense. Many government reports and private experts have criticized recent efforts as wasteful, poorly coordinated among some 40 federal agencies and ill suited for dealing with a wide spectrum of possible threats.
The Clinton administration, rocked by terrorist attacks on Americans at home and abroad, embarked on a wide but sporadic campaign to build civil defenses. Among other things, the campaign established a national stockpile of drugs and vaccines and on Sept. 11, [Tommy George Thompson (born 1941)], secretary of the Department of Health and Human Services, authorized the first shipments from it, sending truckloads of emergency drugs, bandages, dressings and other medical supplies to New York City.
Even so, Dr. O'Toole of the Johns Hopkins center said, the nation has vaccines or drugs to combat only about a dozen of the 50 pathogens thought to be the likeliest threats.
As part of the stockpile push, the disease control centers last year awarded a $343 million contract for making 40 million doses of smallpox vaccine, the first of which is due in 2004. The disease is a contagious killer of high fevers and open sores.
Though smallpox was eliminated from human populations in the late 1970's, stocks of the virus still exist and making vaccine has become a priority as worries over bioterrorism have grown.
The United States has on hand roughly 7.5 million vaccine doses, said Dr. Tucker in ''Scourge,'' a new book on smallpox. That amount, he added, is ''inadequate to cope with even a medium-sized outbreak that might result from a bioterrorist attack.''
This year, federal and private officials met to act out how the government would cope with a smallpox outbreak. The exercise, code named Dark Winter, ended in chaos when the spreading disease overwhelmed all attempts at containment.
''Most state and local governments have not begun to address the issues that Dark Winter presented,'' Mr. Hauer told a House Government Reform subcommittee in July. ''An incident using biological agents will likely go unnoticed for days, and the typical response of the first responders will have little impact. It is not a 'lights and sirens' type of incident.''
In the last few years, New York City has quietly undertaken many efforts to counter attacks with deadly chemicals or germs.
One program, the kind that the disease control centers called for nationally on Sept. 11, monitors patterns of emergency hospitalizations. Another trains city police officers and firefighters to handle such emergencies, including the decontamination of materials and people.
Stephen S. Morse, a biologist at Columbia University who directs its Center for Public Health Preparedness, which is part of a new national network of such groups run by the disease control centers, recently helped the city set up a program for training school nurses as well.
''Their main role would be sheltering people and ministering in the shelters,'' Mr. Morse said. ''You hope for the best, and prepare for the worst.''
The Defense Department, meanwhile, is continuing a wide effort, begun in the Clinton administration, to have university scientists and biotech companies come up with innovative ways to combat a variety of disease agents.
2001 (Sep 28) - https://www.newspapers.com/image/284183269/?terms=%22jerome%20hauer%22&match=1
2001-09-28-the-jackson-tennessee-sun-pg-2-trucking-companies
https://www.newspapers.com/image/526414920/?terms=%22jerome%20hauer%22&match=1
2001-09-30-the-indiana-gazette-pg-b-1
2001-09-30-the-indiana-gazette-pg-b-1-clip-bioterrorism
https://www.newspapers.com/image/526414928
2001-09-30-the-indiana-gazette-pg-b-2-clip-bioterrorism
https://www.newspapers.com/image/408443138/?terms=%22jerome%20hauer%22&match=1
2001-10-03-the-daily-news-new-york-pg-5.jpg
https://www.newspapers.com/image/630259737/?terms=%22jerome%20hauer%22&match=1
2001-10-04-the-charlotte-observer-pg-7
2001-10-04-the-charlotte-observer-pg-7-clip-bioterrorism
https://www.newspapers.com/image/408483804/?terms=%22jerome%20hauer%22&match=1
2001-10-13-the-daily-news-new-york-pg-27-clip-bioweapon
Although the F.B.I. was notified on Sept. 25 about a suspicious letter sent to NBC, neither the letter, nor the powder residue inside them were tested until nearly five or six days later, and then only because a private doctor notified city public health officials about a troubling skin condition in the news assistant who had handled the mail, officials acknowledged yesterday.
[Note: Only one letter was reported belatedly to New York City officials. The second letter was not initially known to the F.B.I. ]
In fact, the F.B.I. laboratory neither performed nor sought any tests on the powder or the skin samples taken from the employee, identified as Erin M. O'Connor, a 38-year-old assistant to Tom Brokaw.
"That, unfortunately, did not take place," said Barry W. Mawn, assistant director in charge of the F.B.I.'s New York office.
He also said the agents had intended to interview Ms. O'Connor soon after they learned of the case, but did not, for reasons he did not explain.
F.B.I. officials said investigators picked up the envelopes on Sept. 26, the day after NBC security officials called the agency. New York City officials were not informed of the preliminary inquiry until days later.
Indeed if the Health Department had not been alerted to the case by a private doctor, it might well have hibernated in the F.B.I. files.
Mr. Mawn said yesterday that the agency had to investigate dozens of threats, scares and false alarms, and that is how this case was initially treated. Since Sept. 11, when the two planes slammed into the World Trade Center, city and federal law enforcement officials have received hundreds of reports of menace and foul play ranging from bomb threats to chemical attack scares.
The discovery of a case of apparently deliberate anthrax poisoning in the heart of New York City is just the latest in a string of terrifying events that have challenged the law enforcement and health care infrastructure in the last month. It pushed health care officials to nail down a pathogen that most of them had no experience with.
And it once again tested the fragile relationship that has always existed between the New York City Police Department and the F.B.I., agencies that are forced to work in tandem on unprecedented and constantly evolving crimes.
"Information sharing between the F.B.I. and the N.Y.P.D. has always been poor," said one person who has worked closely with both agencies. "There is often a lack of willingness on the F.B.I.'s part to share information, although it is getting better. As they move forward, clearly the F.B.I. is going to have to be more forthcoming."
In this case, Mr. Mawn said, the gravity of the situation was not fully appreciated by the federal authorities until recently.
Between Sept. 19 and Sept. 25, Ms. O'Connor handled a letter postmarked from St. Petersburg, Fla., filled with white powder, according to law enforcement officials. She also handled a second letter containing a sandy substance. Network officials, immediately suspicious, called the F.B.I. The F.B.I. and the New York police both learned of it on Oct. 12, and on the 13th, it tested positive for anthrax.
Then, the agency began to prepare a cover letter for its own laboratory indicating that the substances needed to be tested, but the letter was never completed and the evidence was never sent from the F.B.I.'s office in New York to its laboratory, said Joseph Valiquette, an F.B.I. spokesman.
He added that some delays happened because investigators were unable to interview Ms. O'Connor to supplement the cover letter. "We wanted to send a complete package to the laboratory," said Mr. Valiquette. So none of it was sent. Mr. Valiquette said he did not know why the F.B.I. could not speak with Ms. O'Connor, who works in Rockefeller Plaza and lives in the metropolitan area.
On Sept. 28, Ms. O'Connor developed a strange sore on her chest. Nervous, she went to see Dr. Richard Fried, a Manhattan infectious disease specialist, said Dr. Annetta Kimball, the doctor covering for Dr. Fried, who could not be reached last night.
Armed with the description of the rash — which she described as central scarring surrounded by a lot of swelling — the doctor likely consulted his textbooks to nail down what was going on. Dr. Kimball said that Dr. Fried suspected that his patient had been exposed to anthrax, and immediately prescribed Cipro.
"There is a good chance he had never seen anthrax before," said Dr. Kimball. "This is New York City, not an agricultural area." He also took cultures from a wound Ms. O'Connor developed, but those swabs were negative for anthrax, she said.
At some point, officials and Dr. Kimball said, the patient visited a dermatologist.
One of those doctors notified the city's Health Department on Oct. 6 of a possible case of anthrax. The city has among the most sophisticated epidemiologists and public health labs in the country.
Mr. Valiquette said that the F.B.I. learned from the city's Health Department that "this was an issue." The substance eventually made its way to the Centers for Disease Control and Prevention in Atlanta, which went to unusual lengths to identify it. There was little powder to work with, and a power failure in the lab halted the work for nearly a day, said Dr. James M. Hughes of the C.D.C.
"None of this ever did go to the F.B.I. lab," he said.
One of the Ms. O'Connor's doctors ordered a skin biopsy, which was sent to the C.D.C. But by the time the tissue was taken, the patient had begun taking an antibiotic to counter possible anthrax. As intended, that drug degraded the cellular structure of the bacteria. On Wednesday, the city was informed of the case under investigation. The C.D.C. was able to identify the spores of anthrax, and officials were informed of the results early yesterday morning.
Mayor Rudolph W. Giuliani announced the first confirmed case of anthrax yesterday morning at NBC.
He was described by a person who was with him early yesterday as being "three feet off the ground" when he learned that the F.B.I. had not brought word of the developments to city officials earlier.
Mr. Mawn acknowledged that investigators revisited the case after learning of the concerns of the health officials. "A second notification came through to the Department of Health, at which time the evidence response people and the F.B.I. also became involved with it. It was initially assigned to two agents that just covered the lead. And upon that, it was immediately submitted for tests. As you know and as the mayor has talked about, those tests were initially negative."
Yesterday, The New York Times received a letter filled with white powder that was addressed to a reporter, Judith Miller. The Times notified the mayor's office, and city and F.B.I. officials responded immediately. Tests for radioactive and chemical substances were negative, and results from a more definitive test for anthrax DNA by state and federal labs were expected over the weekend.
Coordinating the efforts of the various law enforcement and public health officials is proving tricky — there have been dozens of bomb and other threats around the city since Sept. 11, and the city, which investigates each case, cannot inform the public or other agencies about each one. Just yesterday, the city heard of about a half dozen cases of suspicious powder or envelopes that it is investigating, the mayor said.
"If there was a problem, it was in the way they first investigated it," one Police Department official said of the F.B.I.'s performance.
But there was some concern last night among health care experts about the delay in the testing. The inability of the agency to identify the substance was "not very comforting," said one C.D.C. official, who spoke on the condition of anonymity. "That is a little disappointing, to say the least."
Anthrax spores, if kept under appropriate conditions — sealed and unexposed to lots of light — can be preserved for years, said Jerome M. Hauer, the former director of the Office of Emergency Management and currently managing director of Kroll Inc. , an investigation firm. He added: "You don't want them sitting around. In this environment, you hope there is good information sharing, especially when it involves biological agents."
Yesterday, soon after the United States Capitol closed, and the world learned that more than two dozen people on the Senate majority leader's staff had been exposed to a potent form of anthrax, and Gov. George E. Pataki and other state workers began taking Cipro, and environmental testing began at City Hall, Mayor Rudolph W. Giuliani held a news conference with four large puppets.
The puppets were part of an effort to publicize a cultural festival. But the message went beyond tourism.
It was part of Mr. Giuliani's studied effort to appear calm, even relaxed, in the face of scary news and general uncertainty. At the heart of Mr. Giuliani's message, one he is increasingly alone in urging, is a conviction that panic can be as damaging, perhaps even more damaging, than germs, and that things could be worse. ''So far this is all very, very psychological,'' he said yesterday, before making a reference to the London blitz of World War II. ''We're not being bombed every day, like the people of London were bombed every day and still able to go on with their lives. So we can be just as brave as they were. This is easy, a lot easier than what they went through.''
Other officials, including President Bush and Governor Pataki, have urged Americans to live normal lives, to triumph over fear. But Mr. Bush's administration has also issued terrifyingly vague warnings of more terror to come. Mr. Pataki is evacuating state offices and is taking antibiotics after anthrax bacteria were found in his Manhattan office suite. Public health experts now say there is no need to take antibiotics before being tested.
Mr. Giuliani says that against the advice of people close to him he is taking no medicines for anthrax. At news conferences filled with questions about fear, he still talks about the Yankees, encourages people to go to restaurants and peppers the conversation with joking asides. ''A little culture,'' he said yesterday, before he tugged at the snout of the elephant puppet. ''This is the kind of culture I like. Not like anthrax cultures.''
Somebody sneezed. ''Want to get checked?'' the mayor said.
He wasn't serious. ''Only kidding,'' he said. ''We've got to joke about this. It's the only way we're going to all get through it.''
He does not mock those who are fearful. He answers hundreds of questions, doles out information and, after a month of daily funerals and anthrax scares, acknowledges that these are frightening times.
''This is very uncharted territory that everybody is in,'' he said yesterday.
Like officials in Albany and Washington, Mr. Giuliani seeks to balance the appetite for information against the potential for hysteria. But his tone is distinctive. He seems to lean harder than most against panic.
''Obviously there are two competing points of view here,'' said Dr. Richard Fried, a Manhattan specialist in infectious diseases who treated the woman at NBC who contracted anthrax. ''There is the necessity for public officials to keep people free of a panic and to be realistic about what the threat is. And those two paths intersect along the way.''
Here is what he is up against: Every day for almost a week, there has been a new anthrax scare in an office building in New York City and in other places around the nation. A vast majority have been false alarms, but two New Yorkers have been infected. Offices, including his own yesterday, have been tested for contaminants. He must convey a flurry of medical and technical information to people who have already watched two office towers fall and heard of a baby who became ill with anthrax after visiting an office building for a birthday party.
But his demeanor is calm, at times insouciant. He speaks frequently of dining out. He likes it, and wants others to do more of it. When he is questioned beyond what he thinks is reasonable during his daily briefing, he will abruptly turn the topic to sports.
On Sunday, a reporter asked: ''There's a suspicion in Edison, N.J., of a Ford worker that perhaps this individual was exposed to anthrax. Could you update us on the status of that?''
Mr. Giuliani replied: ''Could somebody update me on the Giants score? You have the Giants score, Steve? Giants winning? Good. And we've got a big Yankee game this afternoon. Unbelievable game last night, unbelievable. Almost got a heart attack.''
The reporter tried to continue: ''There was a report this morning that . . .'' The mayor cut the reporter off. ''Can you imagine what Mariano Rivera must be like?'' Mr. Giuliani said. ''He probably has like ice water in his veins.''
He tries to draw lines, at least on the surface, to divide his many messages. Puppets are ushered out when his health commissioner comes into a room for a briefing, and he rarely updates the number of dead at a news conference for lighter matters. He can sometimes seem a bit detached, insisting that most New Yorkers are not afraid when conversations around the city suggest otherwise.
The mayor has also chosen to play down the facts of one case, without altering its essential truth, apparently to keep the lines between threat and fear starkly drawn.
For instance, while he immediately acknowledged that a baby whose mother took him to ABC News had shown symptoms of anthrax exposure, he never revealed that the baby had fallen quite ill and that his kidneys nearly failed. The child was given antibiotics and has recovered.
And while Mr. Giuliani said that everything was being tested at ABC, behind the scenes, ABC executives revealed this week, he was holding the F.B.I.'s feet to the fire, deeply displeased with the speed at which the bureau was working. For security reasons, he and his police commissioner are loath to give out the sort of details that would provide the most comfort, such as what the city is doing to secure the subway system. The mayor's own public schedule is held under tighter wraps than usual.
''I think it is always a very difficult question, how much information you give out,'' said Jerome M. Hauer, the former head of the mayor's Office of Emergency Management. ''It is important that you give information out on a frequent basis, but it has to be accurate. You can't let the desire for information drive it. Because inaccurate information can be very very harmful, as we have seen that over the years with the Internet.
''The balance you have to strike is realizing that we live in an era where there are threats now, and letting people know that you can't succumb to these threats,'' Mr. Hauer added. ''I think the mayor is right on this. We need to be cautious, but we can't crawl into holes. We need to go about living.''
Correction: Oct. 19, 2001
A news analysis article yesterday about Mayor Rudolph W. Giuliani's response to anthrax fears referred imprecisely to the closings of government offices in Washington. While all six House and Senate office buildings were closed for further screening, the Capitol was not closed. The article also referred incorrectly to the consensus of public health experts about treatment in cases like that of Gov. George E. Pataki, who decided to take antibiotics without first being tested to see if he was exposed to anthrax found in his Manhattan office. Many experts advise taking antibiotics immediately. There is no consensus that taking antibiotics should be postponed until after testing.
A number of health officials and experts are warning that steps being taken by the government and members of the public in response to threats of bioterrorism carry health risks that may far exceed their benefits.
These experts are focusing on two developments: the rising interest in powerful antibiotics to counter anthrax and the possibility of renewing mass vaccinations for smallpox.
Antibiotics and vaccines, like all medicines, can have harmful side effects, the experts say. In addition, the soaring sales of Cipro -- a powerful antibiotic widely if erroneously believed to be the only effective drug against anthrax -- raise the prospect that if large numbers of people start taking it, anthrax and other far more common bacteria will become resistant to it.
''Our big problem is not bioterrorism,'' said Dr. Lucy Shapiro, a microbiologist who heads the Arnold and Mabel Beckman Center for Molecular and Genetic Medicine at Stanford University. ''It's our response that's going to lead to a big jump in antibiotic resistance. That's the terror.''
The smallpox question arose last week, when the federal government announced that it planned to stockpile 300 million doses of smallpox vaccine, enough to immunize everyone in the country. ''Sometime in the future there may be a discussion that may lead to voluntary vaccination for the smallpox bug,'' said Tommy G. Thompson, the secretary of health and human services.
But some public health experts question the wisdom of vaccinating Americans in the absence of any cases of smallpox anywhere in the world. As with antibiotics for anthrax, they say, in the event of a smallpox outbreak there should be time to get the vaccine to most people who were exposed.
Dr. Jonathan B. Tucker, a bioterrorism expert at the Washington office of the Monterey Institute of International Studies and the author of ''Scourge: The Once and Future Threat of Smallpox'' (Atlantic Monthly Press, 2001), said the vaccine could prevent the disease from spreading to those who came in contact with an infected person, providing substantial immunity 10 days after vaccination.
''Even within five days, while there is some risk of disease, it probably will not be life-threatening,'' Dr. Tucker said. ''That means there is somewhat less of an imperative to vaccinate prophylactically.''
In the absence of disease, it does not make sense to reinstitute vaccinations, he said.
''Given that this is a live virus vaccine, there is a small but significant risk of serious complications,'' Dr. Tucker said, adding that one in a million who were vaccinated in the 1960's died or had brain damage. The vaccine can cause severe infections in one of 18,000, with the virus spreading throughout the body.
Routine vaccinations against smallpox were discontinued in the United States in 1972, when the disease had been virtually eradicated worldwide. A new vaccine would be made with more modern methods. Nevertheless, experts caution that some side effects are inevitable.
Dr. Tucker noted that a recently vaccinated person can spread the virus to others, possibly making them ill. This was one reason the Pentagon stopped vaccinating troops for smallpox, he said, adding, ''They would have to quarantine those who were vaccinated so they wouldn't spread the virus to their families.''
As for anthrax, some health experts point out that only a handful of people have developed the disease, with one death so far, and a few dozen more have tested positive for exposure to anthrax spores.
''What we're seeing now, in the big picture of a public health impact is relatively minor,'' said Dr. Anthony S. Fauci, director of the National Institute of Allergy and Infectious Diseases. ''It's high on terror and low on impact.''
Health experts say they know firsthand how terror can make even the most rational person reach for a bottle of Cipro. But they say that makes it all the more important to spread a temperate message.
''I was in the ABC and CBS newsrooms on Wednesday,'' said Dr. Allan Rosenfield, the dean of the Mailman School of Public Health at Columbia University. ''On Thursday night, I came down with a sore throat and a fever.''
Anthrax infections have been found in a CBS News employee and in an ABC producer's baby. Dr. Rosenfield could not help thinking of the disease, and he could not help being tempted to start taking Cipro. But ''I didn't take anything,'' he said. ''I was proud of myself.''
The next day, Dr. Rosenfield said, he had a few qualms. ''I said, 'If I made a mistake, I'm dead.' '' He has now recovered. He does not have anthrax.
Dr. Shapiro, the Stanford microbiologist, acknowledges that she was shaken by the terrorist attacks. ''I'm scared,'' she said, but added that she, too, was not taking antibiotics.
''They don't have to kill us with anthrax,'' Dr. Shapiro said, referring to the prospect that diseases might develop a resistance to antibiotics. ''They can just change the whole flora and fauna of our pathogen world. This is about the worst thing that can happen in our war on bugs.''
Then there is the problem of antibiotic side effects. These can vary from nausea and diarrhea to much more serious medical conditions.
''Antibiotics are justified to treat infections,'' said Dr. Timothy T. Flaherty, who is chairman of the board of trustees of the American Medical Association. ''But without infections, all you're left with are side effects.''
Some public health experts warned against hasty reactions to the terrorist threat.
Jerome M. Hauer, a former director of New York City's Office of Emergency Management who advises Mr. Thompson on bioterrorism, added his own word of caution when it came to smallpox. ''I think you've got to be careful,'' Mr. Hauer said, ''about public pressure pushing you into medical decisions that could at the end of the day be harmful.''
By Reed Abelson and Robert Pear / Oct. 30, 2001 / Source : [HN01ML][GDrive]
For all the government's talk about a stockpile of antibiotics and other medical supplies that can be delivered anywhere in the nation in 12 hours, it is not at all clear that federal officials can actually get drugs or medical supplies to millions of Americans that quickly.
Only about 15 percent of the medicines and supplies that make up the National Pharmaceutical Stockpile is actually in the hands of the government. Many are held by the manufacturers, who are supposed to deliver them rapidly if the government requests it. The Centers for Disease Control and Prevention, which oversees the stockpile, is still in the early stages of assembling its supply and is scrambling to line up suppliers.
Delivering the drugs into the hands of people who need them is another significant challenge, according to public health officials and bioterrorism experts. The government must be able quickly transport huge quantities of medicine and equipment, and the plans to move supplies were described as ad hoc in a government study earlier this year. In addition, many local health authorities, especially in rural areas, seem ill-prepared to handle them.
Federal officials say they are well prepared to treat anthrax, for example, with enough drugs at the government's disposal to treat as many as two million Americans for 60 days. ''We have the drugs that we need,'' Tommy G. Thompson, the secretary of health and human services, testified earlier this month. ''They will be available whenever and wherever they are needed.'' The government has also promised to accumulate enough anthrax drugs in the next 12 months to treat 12 million people.
But responding to a bioterrorist event is a ''massive'' undertaking, according to Gov. James S. Gilmore III of Virginia, a Republican who is leading a federal commission examining the nation's ability to handle a biological or chemical attack. ''We don't think it's been carefully prepared and thought out on a national level,'' he said.
Created in 1999, the national pharmaceutical stockpile was designed as a supply of drugs and medical and surgical equipment that could be sent quickly to the scenes of disasters, including biological or chemical attacks. In addition to antibiotics for anthrax, for example, the stockpile includes treatments for diseases like plague and tularemia and equipment like oxygen masks.
The government's rapid response plan relies on eight so-called push packages, which are pre-assembled sets that contain 84 or more different medical supplies, ranging from antibiotics to intravenous supplies. While the C.D.C. would not discuss exactly what the packages contain, each 50-ton set is stored in an undisclosed location around the country and is available to be shipped anywhere in the country within 12 hours.
The C.D.C. would not provide specifics on the packages, but one official said they contained about 15 percent of the overall stockpile. ''Something on that order is accurate,'' said Steven A. Adams, deputy director of the National Pharmaceutical Stockpile program at the C.D.C.
The government said it planned to add four more push packages within the year.
There is considerable confusion over whether the packages have enough antibiotics for two million Americans. ''These push packs have enough drugs to treat two million persons for inhalation anthrax,'' Mr. Thompson told Congress last week. But a C.D.C. official later explained that some of that supply was not in the push packages, but in another part of the inventory.
While the C.D.C. has refused to say how many people could be treated solely by the push packages, Mr. Adams said that they were entirely made up of ''physical inventory that we own, and it's rapidly deployable.''
The bulk of the stockpile, however, is physically held by the suppliers and is designed to be made available within two to three days of an attack, not the 12 hours government officials frequently describe.
The entire stockpile was just beginning to be assembled earlier this year, according to a March report by the General Accounting Office, an investigative arm of Congress. The government had filled about half of its requirements for the push packages by the time the report was published, and was working with different manufacturers to fill the overall stockpile.
But at the time of the Sept. 11 attack, according to federal officials, the government had contracts for only a fifth of the inventory not in push packages.
To transport supplies, the government has contracted with commercial carriers who will use trucks and planes. In March, the General Accounting Office said that the C.D.C. had not considered all the risks of relying on private contractors to store and transport the supplies, and that the agency was relying on makeshift arrangements to help manage the stockpile.
The government's promises to ship push packages within 12 hours assumes there are planes and trucks available at both ends, roads and airways are open and the weather is good, noted Governor Gilmore.
The government did deliver supplies to New York City within seven hours on Sept. 11, but that was the first time they actually used the stockpile in an emergency.
Officials in other states do not know how quickly they could count on supplies arriving. ''We've never had it tested,'' said Stephen Gleason, the director of the Iowa Department of Public Health. Iowa is seeking to increase its own small stockpile, he said.
The hardest task is distributing the drugs, which are packaged in bulk containers. ''Even if we had every pill and every vaccine imaginable, you need a solid and efficient distribution system,'' said Monica Schoch-Spana, a senior fellow at the Johns Hopkins Center for Civilian Biodefense Studies.
The federal government plans to send a small team of pharmacists and public health officials, but local health professionals such as doctors, nurses and pharmacists are also needed to explain treatments and determine which people should get medicine. ''You don't just throw pills at people,'' she said.
The government can get drugs to where they are needed, said Jerome M. Hauer, a former director of the Office of Emergency Management for New York City who is now an executive with Kroll Associates. But ''it does not mean getting medicine into the hands of people within 12 hours.''
Some states are already thinking about how to contend with the push packages. Health officials in Washington State are trying to arrange for a large health maintenance organization to repackage the pills, according to Dennis R. Anderson, the risk manager for the Washington State Department of Health.
Many local officials are woefully unprepared, however. A survey by the National Association of County and City Health Officials earlier this month found that only 20 percent of the group's members had a comprehensive plan in place to handle a bioterrorist attack.
''We have not seen a comprehensive training and planning program,'' Governor Gilmore said. ''We have to be prepared everywhere.''
As a petite and private woman from the Bronx lies in critical condition at a Manhattan hospital, everything about her life — from the mail she received at home to the desk that she used at work — is being urgently scrutinized in a broad investigation into the way she contracted the city's first case of inhalation anthrax.
Public health experts and law enforcement officials are carefully retracing the recent steps of the 61- year-old woman, Kathy T. Nguyen — creating almost "a diary," one investigator said. They are interviewing co-workers and neighbors. They are conducting environmental tests at the Manhattan Eye, Ear and Throat Hospital, where Ms. Nguyen works in the basement stockroom. They are also testing her home; according to her neighbors, people in protective suits forced open the door to her third-floor apartment early yesterday morning and investigators were still there late into the afternoon.
Health officials said yesterday that the results of their tests so far had not shown traces of anthrax. They also said that Ms. Nguyen could not be interviewed, because she was sedated and breathing with the assistance of a respirator. Making matters even more difficult is that she lives alone, which means that no family member is available to describe where she had gone and what she had done in recent days.
But for all these complications — and for all the uncertainties created by the terrorist attacks of Sept. 11 and other, isolated cases of anthrax — Kathy Nguyen represents a classic epidemiological case: a matter of medical detective work.
"We're not assuming anything," said Dr. Marcelle Layton, an assistant health commissioner for New York City and one of the country's leading communicable-disease investigators. "Like any detective, you have to look at all possibilities."
According to city officials, Ms. Nguyen developed chills and muscle aches on Thursday, and felt sick enough on Friday to mention it to her colleagues at work. Her symptoms intensified over the weekend, and on Sunday afternoon she went to Lenox Hill Hospital's emergency room.
That night, medical staff members at Lenox Hill were able to talk briefly to Ms. Nguyen. One of them, Dr. Michael Tapper, became suspicious when he learned that she worked near the mailroom at the Manhattan Eye, Ear and Throat Hospital and that her responsibilities sometimes included handling mail. Following a protocol set in place by the Department of Health — in which a proximity to mail handling was listed as a possible risk — he called Dr. Layton.
Dr. Neal L. Cohen, the city's health commissioner, said Dr. Tapper's alertness allowed the health department "to turn around what we think is an important diagnosis that had to be made in a short time frame."
In recent weeks, city health officials and investigators from the Centers for Disease Control and Prevention have become all too familiar with anthrax. Isolated cases of cutaneous anthrax have been confirmed at several news organizations in the city, and four mail-sorting machines at a Postal Service sorting center in Midtown have tested positive for anthrax spores.
But Ms. Nguyen "didn't fit what we've seen before — either working for a media organization or being directly associated with the Postal Service," Dr. Layton said. "It was a more indirect connection: she worked near the mailroom."
"It was that subtle connection," she added, that prompted Dr. Tapper's call and set an intensive investigation in motion. "We still don't know that it's the hospital. But we're focusing on it primarily because she worked near a mailroom."
Joseph A. Valiquette, a spokesman for the Federal Bureau of Investigation in New York, said that investigators assigned to the F.B.I.-N.Y.P.D. Joint Terrorist Task Force were "trying to learn as much as we can about her activities over the last couple of weeks — where she has been and who she has come into contact with."
Dr. Cohen said yesterday that the incubation period for most inhalation-anthrax cases was within two weeks. With that in mind, investigators set Thursday, Oct. 11, as the chronological starting point for their inquiry, and are trying to piece together everything they can about Ms. Nguyen's whereabouts from that date. (They are also arranging for anyone who has been inside the Manhattan Eye, Ear and Throat Hospital since that date — patients, employees, visitors — to receive prophylactic antibiotics.)
"We're hoping that something will point us in the direction of where she was exposed," Dr. Layton said.
Toward that end, officials are focusing specifically on the hospital, at 210 East 64th Street, and her apartment, at 1031 Freeman Street in the South Bronx. But Dr. Cohen said that they had not done testing in the subway system in relation to the Nguyen case, in part because "there's no information that there's any unusual cluster" of cases that would indicate greater exposure.
So far, Dr. Cohen said, "We have no information that there's any unusual cluster or a number of cases that would suggest that more individuals, or a large number of individuals, may have been exposed."
Jerome M. Hauer, a bioterrorism expert and a managing director for the investigative firm of Kroll Associates, said that the city's approach was sound. "Trying to understand where she came into contact with anthrax is one of the first things you have to do," by testing swipes of the mail-handling equipment, and every aspect of her environment at work and at home, he said. '
Mr. Hauer said that if it turns out that Ms. Nguyen was infected by a piece of mail, it would open a wide avenue for further investigation: Where did the letter come from? Who had contact with it? Was it a case of cross-contamination with another letter? Did it come through one of the post offices where traces of anthrax have already been found?
"But from an epidemiological point of view, at least you have found the source of her illness," he said. "That solves one of your problems."
2020-05-27-wallmine-com-jerome-hauer-net-worth-2021.pdf
https://wallmine.com/people/32708/jerome-m-hauer
LAST UPDATED: 27 MAY 2020 AT 5:12PM EST
The estimated Net Worth of Jerome M Hauer is at least $3.45 Million dollars as of 26 May 2020. Jerome Hauer owns over 4,385 units of Emergent Biosolutions Inc stock worth over $614,235 and over the last 14 years he sold EBS stock worth over $2,481,956. In addition, he makes $352,500 as Independent Director at Emergent Biosolutions Inc.
Jerome has made over 13 trades of the Emergent Biosolutions Inc stock since 2011, according to the Form 4 filled with the SEC. Most recently he sold 4,385 units of EBS stock worth $373,383 on 26 May 2020.
The largest trade he's ever made was selling 10,776 units of Emergent Biosolutions Inc stock on 15 August 2017 worth over $386,104. On average, Jerome trades about 2,448 units every 117 days since 2006. As of 26 May 2020 he still owns at least 10,188 units of Emergent Biosolutions Inc stock.
*** Emergent BioSolutions : Narcan, vaccines, etc : https://en.wikipedia.org/wiki/Emergent_BioSolutions .. BioPort, Anthrax... more ..
You can see the complete history of Jerome Hauer stock trades at the bottom of the page.
Dr. Jerome M. Hauer, Ph.D., is an Independent Director of the Company. He previously served on our Board of Directors from May 2004 to October 2011. Currently, Dr. Hauer is a senior advisor at Teneo Risk in New York City and Washington, D.C. and a visiting professor at Cranfield University/Defence Academy of the United Kingdom. Before joining Teneo Risk, Dr. Hauer served from January 2012 until December 2014 as the Commissioner of New York State Division of Homeland Security and Emergency Services and Chairman of the Executive Committee on Counterterrorism. Formerly, Dr. Hauer served as chief executive officer of The Hauer Group from 2006 to 2011 and as senior vice president and co-chair of the homeland security practice of Fleishman-Hillard Government Relations from January 2005 to March 2006. Prior to joining Fleishman-Hillard, Dr. Hauer served as acting assistant secretary for the office of public health emergency preparedness at HHS from June 2002 to November 2003 and as director of the office of public health preparedness of HHS from May 2002 to June 2002. Dr. Hauer served as the first director of the New York City Mayor's Office of Emergency Management under Mayor Rudolph Giuliani. He also served as the director of Emergency Medical Services and Emergency Management as well as director of the Department of Fire and Buildings for the State of Indiana under Governor Evan Bayh. Dr. Hauer holds a Ph.D. from Cranfield University/Defence Academy of the United Kingdom. He received an M.H.S. in public health from Johns Hopkins University School of Hygiene and Public Health and a B.A. from New York University. Hauer's qualifications to serve on our Board of Directors include his significant experience in various governmental and public health organizations, as well as his experience on other boards.
As the Independent Director of Emergent Biosolutions Inc, the total compensation of Jerome Hauer at Emergent Biosolutions Inc is $352,500. There are 9 executives at Emergent Biosolutions Inc getting paid more, with Robert Kramer having the highest compensation of $3,693,820.
Jerome's mailing address filed with the SEC is 400 PROFESSIONAL DR, SUITE 400, , GAITHERSBURG, MD, 20879.
Over the last 15 years, insiders at Emergent Biosolutions Inc have traded over $130,968,913 worth of Emergent Biosolutions Inc stock and bought 1,647 units worth $26,601 . The most active insiders traders include Seamus Mulligan, Fuad El Hibri, and Shahzad Malik. On average, Emergent Biosolutions Inc executives and independent directors trade stock every 17 days with the average trade being worth of $1,132,466. The most recent stock trade was executed by Louis W Sullivan on 10 May 2021, trading 10,305 units of EBS stock currently worth $192,085.
https://www.youtube.com/watch?v=O1RWqfR63NA
Vaccines during the COVID-19 Pandemic - Prof. Jerome Hauer
May 8, 2020
World Association for Disaster and Emergency Medicine
As the work on a COVID-19 vaccine continues, Prof. Jerome Hauer discusses vaccine development, Oxford Vaccine Group and Operation Warp Speed, and lessons for future infectious disease management.
Prof. Hauer is currently an Associate Editor of the Journal of Special Operations Medicine and a Visiting Professor at the Defence Academy of The United Kingdom/Cranfield University. The podcast was recorded on 8 May 2020.
2020-05-08-youtube-world-association-for-disaster-and-emergency-medicine-vaccines-during-cov19-jerome-hauer-720p
2020-05-08-youtube-world-association-for-disaster-and-emergency-medicine-vaccines-during-cov19-jerome-hauer-img-1.jpg
https://www.youtube.com/watch?v=iWAiAevjWDw
Jul 11, 2007
Jerry Hauer "Absolutely" Favored Emergency Center Location
https://www.youtube.com/watch?v=1dXkaF0NvIM
1,182 views•May 23, 2007
Jerry Hauer says he "absolutely" favored emergency command center location. WCBS' "Kirtzman & Co." -- 5/9/04
https://www.youtube.com/watch?v=DRVGhyqpNec
Dec 4, 2012
In 1983, Hauer joined IBM where he was responsible for the company's Hazardous Materials Response and Crisis Management and Fire Safety programs. Hauer produced a series of hazardous materials training videos that earned him the International Film and TV Critics of New York Bronze award in 1986.
In the early 1990s, Hauer got his first contacts to military and biodefense. Hauer received a master's degree in emergency medical services from the Johns Hopkins School of Hygiene and Public Health. Then he became member of the Johns Hopkins Working Group on Civilian Bio Defense, where he wrote various articles about a possible bioterrorist attack.
In 1998, he started working at the OEM (Office for Emergency Management) in New York.
In the same year, Hauer and anthrax suspect Hatfill both supported the CFR as experts in their respective fields. The CFR is an acronym for Council on Foreign Relations, one of the most important think-tanks advising the US government, as well as many other governments abroad.
CFR members include the Pentagon's top advisers, Richard Perle, Henry Kissinger, Deputy Defense Secretary Paul Wolfowitz, ex-CIA chief James Woolsey, biosciences specialist Joshua Lederberg, and many others.
On May 28, 1998, Hatfill and Hauer spoke together at the same CFR meeting about "Building a 'Biobomb': Terrorist Challenge" Hatfill was at that time also Senior Research Associate at the U.S. Army Medical Research Institute for Infectious Diseases (=USAMRIID) .... Anthrax weeks later
Tuesday, 13 August 2002, 5:10 pm / Article: www.UnansweredQuestions.org / Source : [HW006P][GDrive]
[...]
"Very few cities at this point in time are prepared to manage the consequences of bio-terrorist attack."
Jerry Hauer in an interview with Eyewitness News, October 1, 2001
http://abclocal.go.com/wabc/news/WABC_investigators_100101bioterror.html
In May 2002, Jerome Hauer became director of the federal Office of Public Health Preparedness (OPHP), succeeding Dr. D. A. Henderson from Johns Hopkins Institute.
Why is Jerome Hauer not making national news yet?
He's becoming famous on the Internet. Not only for Republicans, who appreciate his long fight against bioterrorism, which he started three to four years ago.
Hauer is also controversial among those who are able to connect the dots between his person and shady business deals in biopharmacy since 1998.
More interesting, he seems to have had prior knowledge about both so called terrorist-attacks: September 11th and Anthrax.
But many private investigators claim since months, he let the attacks happen on purpose to continue his career.
Is Hauer LIHOP suspect No.1?
He started to work for the NIH under Tommy Thompson on September 10, 2001 as an adviser on national security. On September 11th, he told the White House to take Cipro, the antibiotic that works against the anthrax virus, without bothering to reveal his warning to the American nation.
http://www.bayarea.com/mld/bayarea/living/health/3020501.hym
The watchdog group JudicialWatch decided to file a lawsuit against the NIH, but also against the FBI, CDC and the White House, for the same reason: Prior Knowledge.
It is not known how long Hauer worked at the NIH before Sept. 11, but we can confirm that he was working on Sept. 10.
http://www.lauriegarrett.com/wtc_day12.html
But things get really interesting when we consider that Jerome Hauer was also the man who in August 2001 arranged a new job for John O'Neill - the resigning chief of the FBI Terror Task Force - as head of security at the World Trade Center.
How did Hauer know that the Twin Towers would be so important?
We would like to ask John O' Neill, but there is one problem: O'Neill died in the towers on September 11th, one day after he started his job officially, according to the New Yorker.
Disturbingly, O'Neill has never been received the same hero status in the mass media as has been accorded to the fallen New York firefighters and police officers. His death has gone without the same fanfare. For 11 months his story went untold, with two big exceptions.
The two French intelligence specialists Brisard and Dasquie (see: http://intelligenceonline.fr) published an interview with O'Neill taken before his death in their book, "Bin Laden: The Forbidden Truth." And articles on O'Neill were also published in the New Yorker and New York Magazine. Last week, TIME magazine also tried to remember him, but left out the most important angles.
This should change immediately.
There is obviously a lot which has been hidden from us, but for what reason?
This might have something to do with the FBI HQ (O'Neill complained about them), but also with Jerome Hauer - who is a friend of the current prime anthrax suspect, Stephen Hatfill, who was working for the military anthrax program USAMRIID at Fort Detrick and Battelle, a huge pharmacy company with many ties to the CIA.
Hauer and Hatfill worked together at the SAIC's Center for Counterterrorism Technology and Analysis in 1999. The SAIC (Scientific Applications International Corp) later received also a huge BioDefense budget in autumn 2001.
http://www.saic.com/news/nov99/news11-30a-99.html - (Hauer)
http://www.nandotimes.com/nation/story/455218p-3643441c.html - (Hatfill)
But first, more about Hauer:
In 1983, Hauer joined IBM where he was responsible for the company's Hazardous Materials Response and Crisis Management and Fire Safety programs. Hauer produced a series of hazardous materials training videos that earned him the International Film andTV Critics of New York Bronze award in 1986.
In the early 1990s, Hauer got his first contacts to military and biodefense.
Hauer received a master's degree in emergency medical services from the Johns Hopkins School of Hygiene and Public Health. Then he became member of the Johns Hopkins Working Group on Civilian Bio Defense, where he wrote various articles about a possible bioterrorist attack.
http://iml.dartmouth.edu/ists/hauer.html
In 1998, he started working at the OEM (Office for Emergency Management) in New York.
In the same year, Hauer and anthrax suspect Hatfill both supported the CFR as experts in their respective fields. The CFR is an acronym for Council on Foreign Relations, one of the most important think-tanks advising the US government, as well as many other governments abroad.
CFR members include the Pentagon's top advisers, Richard Perle, Henry Kissinger, Deputy Defense Secretary Paul Wolfowitz, ex-CIA chief James Woolsey, biosciences specialist Joshua Lederberg, and many others.
On May 28, 1998, Hatfill and Hauer spoke together at the same CFR meeting about "Building a 'Biobomb': Terrorist Challenge"
http://www.cfr.org/public/resource.cgi?meet!102
Hatfill was at that time also Senior Research Associate at the U.S. Army Medical Research Institute for Infectious Diseases (=USAMRIID)
Hauer seems to specialize in the art of holding down several different jobs at the same time. While he started to work for the NIH in September 2001, he remained a Managing Director at Kroll Associates - the official security and bodyguard company for all American presidents since World War II!
With Hauer's many sources of insider information (e.g. Kroll/President bodyguards) , it makes sense that he also knew about the CIA briefing for George Bush on August 6, 2001, about warnings of an imminent terrorist "attack with planes."
Hauer is still trying to save the world.
On November 6th, 2001 he participated in the "Independent Task Force on America's Response to Terrorism" at the CFR. Participants there included James J. Zogby (President of the Arab American Institute and Central Asian Enterprise Fund), Newton L. Gingrich (Chief Executive Officer, The Gingrich Group), Harold Brown (former secretary of defense and counselor at CSIS: the Center for Strategic and International Studies), Henry A. Kissinger (Senior Fellow in National Security and European Affairs), Richard C. Holbrooke (Counselor, CFR and Vice Chairman of Perseus, LLC) and Philip A. Odeen (Executive Vice President, Washington Operations of TRW, Inc. and CEO of Reynolds + Reynolds, Dayton).
Their agenda, eight weeks after the attack of Sept. 11, was strange indeed:
http://www.cfr.org/Public/publications/PubDiplom_TF.html
"....Release a White Paper explaining our goals and rationale for the war in Afghanistan, and outlining the evidence that the al-Qa'eda network was responsible for the 9/11 attacks....
...Disseminate stories of particular victims to convey the range of people killed in the 9/11 attacks-stress range of religions, races, income levels, etc...
...counteract myth that Mossad was behind the attacks by showing Jews killed, etc...
...Routinely monitor the regional press in real time to enable prompt responses..."
Hauer's deep connection to disinformation circles for his own purpose are well known. In 1998, he convinced New York Mayor Rudi Guilliani to develop a vaccine against the West Nile virus - almost one year before this virus broke out in New York.
To this end, Hauer introduced Col. Thomas Monath of Oravax (now Accambis) to Guliani and organised a business deal.
Hauer also continued giving bioterror lectures and writing terror scenario scripts. He organized a July 26, 1999, conference in New York for journalists and "thought leaders," on bioterrorism and "Reporting on Weapons of Mass Destruction - Responsibility, Reliability, Readiness." At the same time, he was heading the West Nile spray operation in NYC.
Bioterrorism and vaccines - a perfect payroll combination for Hauer?
Among the participants at this 1999 conference was Brigadier General Bruce Lawlor of the U.S. Army and the former FBI assistant director, Lewis Schiliro (NYC).
General Lawlor has in the meantime become the Senior Director for Protection and Prevention at the Office of Homeland Security:
http://ksgnotes1.harvard.edu/bcsia/esdp.nsf/bios/lawlorbruce
Lawlor was the first commanding general of Joint Task Force - Civil Support (JTF-CS), located in Fort Monroe, Virginia. JTF-CS is a standing joint task force assigned to U.S. Joint Forces Command. Lawlor has taught at the U.S. Army War College and served as a consultant to the Defense Science Board.
Nothing is known about his further influence in preventing attacks on America.
However, as FBI assistant director, Schiliro supervised several counterterrorism investigations, including the 1993 World Trade Center bombing and the 1998 embassy bombings in Kenya and Tanzania.
But Schiliro gave up supporting Hauer in February 2000, too.
http://www.pbs.org/wgbh/pages/frontline/shows/terrorism/fail/
He left the FBI to move to credit card giant MBNA Corp.
And Schiliro wasn't the only one.
His close friend Louis Freeh - who was replaced in the FBI in August 2001 by Thomas Pickard as the acting head of the Bureau - started a new job as a Senior Vice Chairman at MBNA Corp in early September 2001 and began to collect shares.
http://biz.yahoo.com/t/in/k/krb.html
The background of the MBNA is very interesting. They helped the FBI in tracing the hijackers' credit card transactions, and had a lot of prominent helping hands. Among them was James Kallstrom, the former head of Special Operations, FBI.
BNA also has a controversial status among civil right groups. Since 1996, MBNA CORP has unleashed various bulldozers, dump-trucks and explosives in a savage attack on the Ducktrap Deeryard (major coastal wildlife area on Penobscot Bay, Maine USA) or continued with "dull roar of corporate jet noise".
Then, in April 2001, MBNA also had to deal with cheque fraud. Involved was Intelligent Finance, a Halifax-backed Internet bank and a bogus account for a guy named Vindel.
http://www.mbnasucks.org/kallstrom.html
Also interesting is the bio of another director of the MBNA Corporation: Bernadine P. Healy. She also serves as a trustee of the Battelle Memorial Institute and is President and CEO of the American Red Cross.
http://yahoo.marketguide.com/mgi/biograph.asp?rt=biograph&rn=5570N
On May 10, 2001, a few months before Sept. 11, she testified on "human challenges that we will face during a WMD attack":
http://www.slu.edu/colleges/sph/csbei/bioterrorism/official/congress.htm
The Red Cross and the OEM under Jerome Hauer worked very closely together.
Hauer's connections and insider information seem to be endless!
He also helped with the construction of the New York OEM headquarters known as "the bunker," on the 23rd floor of 7 World Trade Center.
http://www.politicsny.com/reports/february02/2-14-02-sheirer.shtml
The CIA later confirmed that they also had an office in that building, next to the Department of Defense and the INS. For unknown reasons, 7 World Trade Center was the third skyscraper to collapse on Sept. 11. Officially, it began burning after debris from the Twin Tower collapses caused an illegal diesel-fuel tank inside the building to explode.
The presence of this large gas tank - also on the 23rd floor - with thousands of gallons of fuel far above ground, in violation of the fire code, was confirmed some weeks after Sept. 11th. There has never been an official verdict on the reasons for the collapse of WTC 7. A FEMA study failed to reach a clear conclusion:
http://www.house.gov/science/hot/wtc/wtc-report/WTC_ch5.pdf
While the collapse of WTC 7 remains a mystery, it cannot be said that the deaths caused by the bio-attack a couple of weeks later were similarly due to incompetence. On the contrary, Hauer had a huge team behind him, and had already warned the White House. Why didn't he leak all his information in time?
In May 2000, the Johns Hopkins Center, in collaboration with the ANSER Institute for Homeland Defense, the Center for Strategic and International Studies, and the Oklahoma Memorial Institute for the Study of Terrorism held a bioterrorism exercise at Andrews Air Force Base. Former Senator Sam Nunn played the President.
David Gergen played the National Security Advisor. Governor Frank Keating played himself, Frank Wisner was Secretary of State, ex-CIA director James Woolsey (ironically) played CIA Director, John White played Defense Secretary, and Dr. Margaret Hamburg was HHS Secretary. The Attorney General was played by George Terwilliger, William Sessions was FBI Director, and Jerome Hauer played FEMA Director.
http://www.hopkins-biodefense.org/pages/library/fema.html
"One of the striking observations of this exercise was the unfamiliarity of these distinguished and experienced professionals with the basic decisions and trade-offs associated with managing the response to the epidemic."
Observing was Tara O'Toole, MD, MPH Senior Fellow, Center for Civilian Biodefense Studies and at that time Deputy Director of Johns Hopkins Institute.
This started a series of different "war games."
On June 22-23, 2001, the same crew organised their last big scenario before Sep11th. They called it DARK WINTER. It was about a possible smallpox attack. Hauer participated as well, this time "playing" the director of the FBI. The whole list is still mirrored at:
http://www.hopkins-biodefense.org/participants.html
http://www.mipt.org/darkwinter06222001.html
http://www.homelanddefense.org/darkwinter/index.cfm
Among the other participants once again:
James Woolsey, ex-CIA director
Hon. Sam Nunn
George Terwilliger etc.
Observing, among many others, Thomas Inglesby, at that time Senior Fellow Johns Hopkins Institute
On July 14th, 2001 the testimony on DARK WINTER was released:
http://www.csis.org/press/ma_2001_0723.htm
But when the first anthrax attacks started, the only thing, which worked perfectly, was the distribution of the anthrax antibiotic Cipro, by Bayer. A couple of weeks later, Barbara Rosenberg of FAS (Federation of American Scientists), the magazine New Scientist, the biowarfare convention specialist Jan van Aken, and the ex-UN inspector Richard Spertzel came to the conclusion that the anthrax was homegrown.
http://www.newscientist.com/news/news.jsp?id=ns99991473
Rosenberg was also supported by Dr. Francis Boyle, a human rights lawyer and professor of law at the University of Illinois. An expert on international law, U.S. criminal law and nuclear weapons, Boyle has studied many different biowarfare contracts in which "safety levels were atrocious." He is also author of "The Criminality of Nuclear Deterrence":
http://www.counterpunch.com/boyle0425.html
Hauer ignored the report by Barbara Rosenberg, but he certainly knew who she was. He first met her on April 10, 1998, at a "roundtable on genetic engineering and biological weapons" under President Clinton. The small group of outside experts and cabinet members present there included: William Cohen (at the time Secretary of Defense), CIA boss George Tenet, Craig Ventner (Celera), Joshua Lederberg (Rockefeller University, Defense Science Board), Thomas Monath (Oravax/Acambis, former CDC and USAMRIID), Hauer, and Barbara Rosenberg.
In November 2001, Hauer was still ignoring the investigations by Barbara Rosenberg, who had already worked out a list of possible anthrax suspects, scientists who would have been able to gain access to the original Ames strain from USAMRIID, Fort Detrick.
http://www.fas.org/bwc/news/anthraxreport.htm
Among the suspects on this list were Battelle and the Battelle Memorial Institute administrators, who supplied the Dugway anthrax proving facility in Utah, where the only virtually identical Ames strain of silica-impregnated hyper-weaponized anthrax was found:
http://www.stlimc.org/print.php3?article_id=1295
Meanwhile, Hauer in November started an initiative known as "De-Mystifying the Biological Weapons Debate," and as a member of this group he claimed at the time that the main suspects for the anthrax attacks included "Osama Bin Laden and his Al-Qaeda network and sympathizers to US right wing extremists"
http://www.basicint.org/BWreport.htm
Therefore we have a lot of questions for him.
Is Hauer in any conflicts of interest?
What was his coordination with FEMA?
Can Hauer confirm, if a FEMA team was already dispatched to New York on September 10, as spokesman Tom Kennedy said in an interview with Dan Rather (CBS, shortly after the attack)?
(INFO: An interview with FEMA director Joe Allbaugh took place on September 12th on CBS at 7:40:20 accirding to the CBS transcript)
On May 8, 2001, Bush announced a new Office of National Preparedness for Terrorism at the Federal Emergency Management Agency. At the same time, he proposed to cut FEMA's budget by $200 million. Bush said that day that Cheney would direct a government-wide review on managing the consequences of a domestic attack.
http://www.washingtonpost.com/ac2/wp-dyn?pagename=article&node=&contentId=A8734-2002Jan19
Bush was aware of a possible attack, that is for sure.
But the questions are:
Did FEMA have prior knowledge as well?
How deep was the communication transfer between Jerome Hauer, the Pentagon, FEMA and the CIA?
Hauer not only knew former CIA director James Woolsey, but also Milt Bearden, who was station commander and had managed America’s covert war in Afghanistan, helping the Moujaheddin drive out the Soviets between 1986-1989. Both spoke at the Nassau Community College (NYC) on October 22, 2001:
http://www.sunynassau.edu/collegerel/news/archives/10_01/102201_3.htm
Hauer's connections to the CDC, Johns Hopkins and the CIA (James Woolsey) are well-established. What role did Jerome Hauer really play?
Why was the distribution of Cipro to White House staff on Sept. 11 classified for such a long time (AP)?
http://www.infowars.com/saved%20pages/Prior_Knowledge/bush_cipro.htm
What exactly does Hauer know about Stephen Hatfill and his former USAMRIID colleague, Thomas Monath?
What was his main concern in organizing a security job for John O'Neill at the Twin Towers?
What exactly did Hauer organise on Sep11th? Is it true that his office ordered thousands of employees "back to their desks" after the first plane hit, causing hundreds of unnecessary deaths?
Did Hauer let both the Sept. 11 and the anthrax attacks happen on purpose?
2020-04-14-mintpressnews-china-how-emergent-solutions-plans-corner-covid-19-cure-market.pdf
2020-04-14-mintpressnews-china-how-emergent-solutions-plans-corner-covid-19-cure-market-screenshot.png
2020-04-14-mintpressnews-china-how-emergent-solutions-plans-corner-covid-19-cure-market-scrolled.mp4
2020-04-14-mintpressnews-china-how-emergent-solutions-plans-corner-covid-19-cure-market-scrolled-1872p-x-1080p.mp4
2020-04-14-mintpressnews-china-how-emergent-solutions-plans-corner-covid-19-cure-market-img-1
https://mintpressnews.cn/how-emergent-solutions-plans-corner-covid-19-cure-market/266615/
4月 14th, 2020
作者 Whitney Webb Whitney Webb andRaul DiegoCommentsFacebookTwitterReddit電子郵件更多...[...][page 17]
March 2, 1998: Security Council agreement, threatening "the severest consequences" if Iraq reneged. Iraq allowed presidential site inspections
April 10, 1998: Jerome Hauer met with Barbara Rosenberg on April 10, 1998, at a "roundtable on genetic engineering and biological weapons" under President Clinton. The small group of outside experts and cabinet members included: William Cohen (at the time Secretary of Defense), CIA boss George Tenet, Craig Ventner (Celera), Joshua Lederberg (Rockefeller University, Defense Science Board), Thomas Monath (Oravax/Acambis, former CDC and USAMRIID), Jerome Hauer, and Barbara Rosenberg. [http://www.fas.org/bwc/news/anthraxreport.htm]
1998: (exact date?): Officials at the Army's Dugway Proving Ground in Utah said that in 1998 scientists there turned small quantities of wet anthrax into powder to test ways to defend against biowarfare attacks. 1998 paper study on anthrax in the mail was one secret project. (Dr Rosenberg is making the astonishing suggestion that there may have been a deadly follow-up by somebody else. Last time she questioned the investigation, she was attacked by the FBI and the White House. But she says she's prepared to speak out again because she's so afraid of what might happen next.) The CIA have told Newsnight they totally reject Dr Rosenberg's theory and say they were unaware of ANY project to assess the impact of anthrax sent through the mail.
1998 (exact date?): BioPort signed a new contract with the US government. They have to develop vaccines against anthrax and have 3 years time for that to finish the production. The vaccines should be available in 2001. They got a $50 million contract for developing AVA (Anthrax Vaccine Absorbed) for 2.5 million US Soldiers 1998, the BioPort Corporation was founded for the express purpose of buying the Michigan Biologic Products Institute from the State of Michigan. MBPI was the only firm in the U.S. making Anthrax vaccine, and their sole client was the U.S. government. Until recently, BioPort has not been able to deliver any vaccine due to continuous problems with the FDA in areas such as sterility, contamination, as well as improper procedures and record keeping.
BioPort now has on its Board of Directors Admiral William J. Crowe, Jr. In October 1985 Crowe was appointed Chairman of the Joint Chiefs of Staff. He retired from that position in 1989 and was appointed US Ambassador to Britain. Admiral Crowe, a long-time member of the Council on Foreign Relations, was given ownership of 22.5% of BioPort's stock without investing any money. Crowe's role at the company was to facilitate cooperation and good relations with government agencies and to secure military contracts from the Department of Defense.
1998 (exact date?): The OraVax company (Bioweapon Vaccines) had been likewise linked to shady backroom dealings with Clinton administration officials in 1998 regarding government orders for a yet to be tested West Nile Virus vaccine. (source: . Dr. Leonard Horowitz, a Public health consumer advocate and author of Death in the Air: Globalism, Terrorism and Toxic Warfare (Tetrahedron Publishing Group; 1-888-508-4787),
http://www.baltech.org/lederman/816proof.html "....The role of Oravax, the commercial vaccine manufacturer directly connected to the major players in this issue-the CDC, the Ft. Dietrick bio-warfare lab, Plum Island, former OEM chief Jerry Hauer and Mayor Giuliani-remains unexamined in the media yet Oravax stands to make billions from its West Nile Virus vaccine if WNV hysteria continues to spread. That Oravax was developing a WNV vaccine before the 1999 outbreak, that its VP went to Washington with Jerry Hauer and the head of Rockefeller University in 1998 to pressure President Clinton to stockpile billions of dollars worth of vaccines or that according to the NY Times, Oravax's stock value had lost 90% of its value-making a mosquito-born epidemic the only chance of company survival-are clues of significance that might prove a financial angle to WNV...."
May 11, 1998: India announces that it has conducted three underground nuclear tests, the country's first since 1974. The tests were conducted simultaneously 330 miles southwest of New Delhi, near the Pakistani border. The Indian government indicates that the three tests included a thermonuclear device, commonly known as a hydrogen bomb. Two days later, on May 13, 1998, India announces that it has conducted two more underground nuclear tests in the same desert range. (WP) (DJ)
May, 1998: Osama bin Laden publicly discusses "bringing the war home to America." [cooperativeresearch.org]
May 1998: Jerome Hauer started working at the OEM (Office for Emergency Management) in New York. In the same year, Hauer and (future) anthrax suspect Hatfill both supported the CFR (Council on Foreign Relations) as experts in their respective fields. The CFR is one of the most important think-tanks advising the US government, as well as many other governments abroad. CFR members include the Pentagon's top advisers, Richard Perle, Henry Kissinger, Deputy Defense Secretary Paul Wolfowitz, ex-CIA chief James Woolsey, biosciences specialist Joshua Lederberg, and many others. On May 28, 1998, Hatfill and Hauer spoke together at the same CFR meeting about "Building a 'Biobomb': Terrorist Challenge" http://www.cfr.org/public/resource.cgi?meet!102
1998 (exact date needed): Jerome Hauer convinced New York Mayor Rudi Guilliani to develop a vaccine against the West Nile virus - almost one year before this virus broke out in New York. To this end, Hauer introduced Col. Thomas Monath of Oravax (now Accambis) to Guliani and organised a business deal. [The Fly on the Wall 0802 News Special, August 13, 2002, 5:10 pm]
[...]
May 2000: R. James Woolsey (CIA Director 1993-95) participated in a bioterrorism exercise at Andrews Air Force Basethe Johns In May 2000 the Hopkins Center, in collaboration with the ANSER Institute for Homeland Defense, (CSIS) the Center for Strategic and International Studies, and the Oklahoma Memorial Institute for the Study of Terrorism held a bioterrorism exercise at Andrews Air Force Base.Former Senator Sam Nunn played the President.David Gergen played the National Security Advisor. Governor Frank Keating played himself, Frank Wisner was Secretary of State, ex-CIA director James Woolsey (ironically) played CIA Director, John White played Defense Secretary, and Dr. Margaret Hamburg was HHS Secretary. The Attorney General was played by George Terwilliger, William Sessions was FBI Director, and Jerome Hauer played FEMA Director. http://www.hopkins-biodefense.org/pages/library/fema.html . The Sudanese government collected a "vast intelligence database on Osama bin Laden and more than 200 leading members of his al-Qaeda terrorist network... [The US was] offered thick files, with photographs and detailed biographies of many of his principal cadres, and vital information about al-Qaeda's financial interests in many parts of the globe." In April 1996, the US again rejects Sudan's offer of the files. An American involved in the secret negotiations later says that the offer was blocked by another arm of the federal government: "I've never seen a brick wall like that before. Somebody let this slip up... We could have dismantled his operations and put a cage on top. It was not a matter of arresting bin Laden but of access to information... and that's what could have prevented September 11. I knew it would come back to haunt us." Sudan again offers the US the files in May 2000, and again is turned down. In 1996 Sudan also offers their files to British intelligence, and are also rebuffed. Sudan makes a standing offer to the British to take the information at any time, but the offer is not taken up until after 9/11. [http://cooperativereseach.org/completetimeline/
[...][bottom of page 47]
June 22-23, 2001, the same crew (see May 2000 re: the Johns Hopkins Center, in collaboration with the ANSER
Institute for Homeland Defense, the Center for Strategic and International Studies, and the Oklahoma Memorial Institute for the Study of Terrorism organised their last big scenario before Sep11th. They called it DARK WINTER. It was about a possible Smallpox attack. Jerome Hauer participated as well, this time "playing" the director of the FBI. The whole list is still mirrored at:
http://www.hopkins-biodefense.org/participants.html http://www.mipt.org/darkwinter06222001.htmlhttp://www.homelanddefense.org/darkwinter/index.cfm Among the other participants once again: James Woolsey, ex-CIA director Hon. Sam Nunn George Terwilliger etc. Observing, among many others, Thomas Inglesby, at that time Senior Fellow Johns Hopkins Institute On July 14th, 2001 the testimony on DARK WINTER was released: http://www.csis.org/press/ma_2001_0723.htm
[...][page 51]
August 19th, 2001: John O'Neill's briefcase with important documents is stolen during a Miami conference and is recovered later.- In the few months leading up to September 11, O'Neill was suddenly the subject of a series of seemingly unrelated controversies –the first, in July, involving his dispute with the State Department over the conduct of the bin Laden investigation in Yemen; and the second, in August, in which he was reported to be under an FBI probe for misplacing a briefcase of classified documents during an FBI convention in Tampa. In the light of the aftermath of this second controversy -- the documents were found, "untouched", a few hours later. Why this seemingly minor news would merit such lengthy coverage in the Washington Post and New York Times a mere three weeks before he was to die in the rubble of the Twin Towers. (in a job arranged for him by Jerry Hauer) (O’Neill had complained that the White House was obstructing his investigation into Bin Laden to protect oil interests) [The mystery surrounding the death of John O'Neill The Propaganda Preparation for 9-11, by Chaim Kupferberg.htm]
[...][page 52]
August 2001: Jerome Hauer arranged a new job for John O'Neill - the resigning chief of the FBI Terror Task Force - as head of security at the World Trade Center.
[...][page 56]
September 10, 2001: Police say that a sixth-grade student of Middle Eastern descent in Jersey City, New Jersey, warns his teacher to "to stay away from lower Manhattan because something bad was going to happen." A few days before 9/11, a Seattle security guard of Middle Eastern descent tells an East Coast friend on the phone that terrorists will soon attack the US; the FBI later verifies the story. Three presumed terrorists talk threateningly in a Florida bar the night before the attacks, one saying: "Wait 'til tomorrow. America is going to see bloodshed [cooperativeresearch.org]
September 10, 2001 John O' Neill celebrated his new job at the Twin Towers together with Jerry Hauer and Robert Tucker, a friend and security-company executive at the China Club, a night spot in midtown.
http://www.nymag.com/page.cfm?page_id=5513&position=1 Other sources claim, he started on August 23rd, the day when the CIA sent their "cable".
September 10, 2001: Jerome "Jerry" Hauer, started to work for the NIH under Tommy Thompson on September 10, 2001 as an adviser on national security. On September 11th, he told the White House to take Cipro, the antibiotic that works against the anthrax virus, without bothering to reveal his warning to the American nation.
www.bayarea.com/mld/bayarea/living/health/3020501.hym Hauer seems to specialize in the art of holding down several different jobs at the same time. While he started to work for the NIH in September 2001, he remained a Managing Director at Kroll Associates - the official security and bodyguard company for all American presidents since World War II!
www.UnansweredQuestions.org The Pentagon was on High Alert on September 10th and didn't allow their employees to fly the following day. [Lihop manifesto]
[...]
Sept. 11, 2001: After the attacks on the World Trade Center and Pentagon occur, National Public Radio's congressional correspondent David Welna reports, "I spoke with congressman Ike Skelton, a Democrat from Missouri and a member of the Armed Services Committee, who said that just recently the director of the CIA warned that there could be an attack -- an imminent attack - on the United States of this nature. So this is not entirely unexpected." [Source: http://www.thememoryhole.org/updates.htm]
Jerry Hauer identifies the dead body of John O'Neill in the rubble of the Twin Towers. He said, that his "remains were nothing the family ought to view" That means, neither O'Neills girlfriend Valerie James, his father John P. O'Neill or his wife or childrens John, Jr., and his younger sister, Carol had been allowed to identify the body. http://www.lauriegarrett.com/wtc_day12.html
Jerry Hauer also helped with the construction of the OEM center known as "the bunker" on an upper floor of 7 World Trade Center. http://www.politicsny.com/reports/february02/2-14-02-sheirer.shtml The CIA later confirmed, that they had an office there. Building 7 collapsed for unknown reasons on September 11th. Officially it started to burn because of an explosion of an illegal gas tank inside the building. This gas tank was confirmed weeks after Sep11th.
[...]
September 21, 2001: Jerry Hauer (now Ex-FBI), National Health Institute assumes on a audtiorium on the Rockefeller campus , that 911 and possible bio attacks are connected with Iraq. http://www.lauriegarrett.com/wtc_day12.html
[...]
October 2, 2001: two days before the first anthrax case was reported in Boca Raton, Florida and a week and a half before the first anthrax was sent through the mail to NBC News in New York - Advanced Biosystems received an $800,000 grant from NIH to focus on very specific defenses against anthrax: Remember that Hauer joined the NIH on September 10, 2001 as an adviser on national security. Told the White House to take Cipro, (anti-anthrax) om Sept 11, didn’t warn the American nation and remained Managing Director at Kroll Associates - the official security and bodyguard company for all American presidents since World War II Hauer also got John O’Neil (ex FBI) his new job at WTC just before sept 11. Coincidence or connection? Hmmmm.
[...]
November 6th, 2001: Jerome Hauer participated in the "Independent Task Force on America's Response to Terrorism" at the CFR (Council on Foreign Relations). Participants there included James J. Zogby (President of the Arab American Institute and Central Asian Enterprise Fund), Newton L. Gingrich (Chief Executive Officer, The Gingrich Group), Harold Brown (former secretary of defense and counselor at CSIS: the Center for Strategic and International Studies), Henry A. Kissinger (Senior Fellow in National Security and European Affairs), Richard C. Holbrooke (Counselor, CFR and Vice Chairman of Perseus, LLC) and Philip A. Odeen (Executive Vice President, Washington Operations of TRW, Inc. and CEO of Reynolds + Reynolds, Dayton).
Their agenda, eight weeks after the attack of Sept. 11, was strange indeed http://www.cfr.org/Public/publications/PubDiplom_TF.html ) :
"....Release a White Paper explaining our goals and rationale for the war in Afghanistan, and outlining the evidence that the al-Qa'eda network was responsible for the 9/11 attacks....
...Disseminate stories of particular victims to convey the range of people killed in the 9/11 attacks-stress range of religions, races, income levels, etc...
...counteract myth that Mossad was behind the attacks by showing Jews killed, etc...
...Routinely monitor the regional press in real time to enable prompt responses..."
November 2001 : Thomas Picking retires from the FBI
November 2001: Jerome Hauer was still ignoring the investigations by Barbara Rosenberg, who had a list of possible anthrax suspects, scientists who would have been able to gain access to the original Ames strain from USAMRIID, Fort Detrick. http://www.fas.org/bwc/news/anthraxreport.htm Suspects were Battelle and the Battelle Memorial Institute administrators, who supplied the Dugway anthrax proving facility in Utah, where the only virtually identical Ames strain of silica-impregnated hyper-weaponized anthrax was found: http://www.stlimc.org/print.php3?article_id=1295 Jerome Hauer started an initiative known as "De-Mystifying the Biological Weapons Debate," and as a member of this group he claimed at the time that the main suspects for the anthrax attacks included "Osama Bin Laden and his Al-Qaeda network and sympathizers to US right wing extremists" http://www.basicint.org/BWreport.htm
[...]